Public tenders for business in Bethesda United States

Find all Business tenders in the world.
Finding business opportunities has never been easier.

Results for business. Make a new search!

HEALTHY MOMENTS

Department of Health and Human Services, National Institutes of Health | Published April 15, 2010  -  Deadline April 30, 2010
cpvs

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is NIHLM-10-0046-1 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-39. The North American Industry Classification (NAICS) Code is 515112 the business size standard is $7.0. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. However, this solicitation is not set aside for small business. The National Institutes of Health (NIH), National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) intends to procure the following services: 50 weeks (one year) of radio time for the Healthy Moments reports delivered by NIDDK Director Dr. Griffin P. Rodgers. Healthy Moments will feature healthy lifestyle tips and other important health information. Through Healthy Moments reports, NIDDK and Dr. Rodgers will convey consistent, reliable, and authoritative health information to African Americans, who are disproportionately affected by diabetes, kidney and some digestive diseases, and other health problems. Healthy Moments audio reports will be broadcast on the radio, posted on the web, and will stream on the web via multiple radio stations that target adult African American listeners across areas in Maryland, Virginia, and Washington, D.C. Healthy Moments reports will be produced and recorded by NIDDK. NIDDK will also provide transcripts plus supplementary web content to the stations for the duration of the contract. The contractor will secure and deliver Healthy Moments reports on-air and via the web, with five radio stations that target adult African American listeners in local areas. Requirements include the following services: broadcasting and streaming a designated number of Healthy Moments audio reports; providing announcements throughout the week to promote those on-air and streaming reports; designing and maintaining accurate, customized, Healthy Moments Web pages for each station's website; creating and displaying web promotions and advertisements for Healthy Moments; building and maintaining a Healthy Moments survey for each station's website; and sponsoring, implementing and promoting an annual contest to promote the Healthy Moments survey. The contractor will also provide consistent feedback to NIDDK on audience impressions and quality control by providing NIDDK with monthly survey results and Arbitron ratings data for each Arbitron book. To ensure quality control is on target, the contractor must supply weekly air checks for each broadcast and offer make-good time for any audio reports or web components that are delivered outside agreed-upon parameters. Basis for Award: Offerors must provide descriptive literature or other material that demonstrates their offer meets the forgoing requirements. The contract will be awarded to the responsible offeror whose offer fully meets the requirements of the solicitation, provides the best value, with price and technical factors equally important in award evaluation. The offeror must include a completed copy of the following provisions: 1) FAR Clause 52.212-1 Instructions to Offerors Commercial; 2) FAR Clause 52.212-2, Evaluation Commercial Items. As stated in FAR Clause 52.212-2 (a), The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: Technical Evaluation, Price, and Past Performance; 3) FAR Clause 52.212-3, Offeror Representations and Certification of Commercial Items; 4) FAR Clause 52.212-4, Contract Terms and Conditions Required To Implement Statues or Executive Orders - Commercial Items, Contract Terms and Conditions - Commercial Items; and 5) FAR Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items Deviation for Simplified Acquisitions. Vendors must submit a listing of the most recent contracts/awards (minimum of 3) in which similar technical services were purchased. Contracts/awards may include those entered within the Federal Government, state and local governments and commercial concerns. Include the following information for each contract or subcontract: 1. Name of Contracting Organization2. Contract Number (for subcontracts provide the prime contract number and the subcontract number3. Contract Type 4. Total Contract Value 5. Description of Requirement to include Statement of Work 6. Contracting Officers Name and Telephone Number 7. Program Managers Name and Telephone Number* If past performance questionnaire is available, please submit. All responses received within 15 days from the date of publication of this synopsis will be considered by the Government. The offeror must include in their quotation, the unit price, the list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. The clauses are available in full text at http://www.arnet.gov/far. Interested vendors capable of furnishing the government with the item specified in this synopsis should submit their quotation to the below address. Quotations (3 copies) will be due fifteen (15) calendar days from the publication date of this synopsis or by April 30, 2010, 12pm, Eastern Standard Time. The quotation must reference "Solicitation number" NIHLM-10-0046-1. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Quotations must be submitted in writing to the National Library of Medicine, 6707 Democracy Blvd., Room 773, Bethesda, Maryland 20817, Attention: V. Lynn Griffin, griffin@mail.nih.gov. Faxed copies will not be accepted.  

Investigational Drug Management System (IDMS)

Department of Health and Human Services, National Institutes of Health | Published March 5, 2014  -  Deadline April 4, 2014
cpvs

This is a combined synopsis/solicitation for commercial services prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-72 effective January 30, 2014. This acquisition will be processed under FAR Part 12, Simplified Acquisition Procedures (SAP), Acquisition of Commercial Items, and is set aside 100% for small businesses.. The Solicitation Number for this acquisition is NIH-CC-P14-001910 and is being issued as a Request for Quotation (RFQ). The North American Industry Classification System (NAICS) Code for this procurement is 541511 and the Small Business Size Standard is $25.5 million dollars. BACKGROUND The NIH Clinical Center Pharmacy Department provides pharmaceutical care and dispenses medications to inpatients and outpatients. Clinical Center pharmacists provide research support to health care providers and investigators. Pharmacy staff members conduct and participate in research programs that enhance knowledge regarding optimal dosing and appropriate use of investigational and commercially available agents. The Pharmacy Department's Pharmaceutical Development Section manages investigational drug inventories through a computerized information system, prepares customized investigational drug products, and assists investigators in filing Investigational New Drug (IND) applications with the FDA. The Department of Clinical Research Informatics (DCRI) is responsible for processes and systems that directly affect users in the care delivery and research settings. Work focuses on the analysis and evaluation of clinical research informatics needs and requirements, the development of design options that support the work processes of clinical research, and the implementation and management of responsive IT solutions. The Investigational Drug Management System (IDMS) is a web application that is used by the Pharmacy Department to track all activities related to investigational drugs used in patients at the NIH, including prescription filling and investigational drug label generation. STATEMENT OF OBJECTIVES The purpose of this proposal is to provide the Clinical Center, Pharmacy Department with maintenance and support services for the IDMS application. The government anticipates awarding an Indefinite Delivery Indefinite Quantity contract that will consist of a base period of performance of 12 months and four 12 month option periods. The level of effort for the base period is a minimum of 400 hours and a maximum not to exceed 1,000hours. The total level of effort if all option periods are exercised will be a minimum of 1,000 hours and a maximum of 5,000 hours. For complete details and specifications in addition to proposal preperation and submitting procedures please refer to the attached combined solicitation\synopsis. Please note that this requirement is for maintenance and support of an existing system and not for the development of an IDMS system. This is not a full time development requirement.

Institutional Review Board (IRB) Management Software

Department of Health and Human Services, National Institutes of Health | Published October 9, 2014  -  Deadline October 16, 2014
cpvs

Introduction: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a sole source noncompetitive basis to provide the Institutional Review Board (IRB) software, iRIS, to iMedRIS Data Corporation, 446 Missouri Court, Redlands, CA, 92373-8083. Background: The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI stimulates basic discoveries about the causes of disease, enables the translation of basic discoveries into clinical practice, fosters training and mentoring of emerging scientists and physicians, and communicates research advances to the public. It creates and supports a robust, collaborative research infrastructure in partnership with private and public organizations, including academic institutions, industry, and other government agencies. The Institute collaborates with patients, families, health care professionals, scientists, professional societies, patient advocacy groups, community organizations, and the media to promote the application of research results and leverage resources to address public health needs. The NHLBI also collaborates with international organizations to help reduce the burden of heart, lung, and blood diseases worldwide. The National Institutes of Health (NIH) was recently awarded AAHRPP accreditation. In order to maintain its accreditation, NIH requires all of its clinical programs to comply with newly implemented standard operating procedures regarding clinical protocol management. These standards are currently enforced through NIH's Office of Human Subject Research Protection. The NHLBI requires new IRB management software. The current system is outdated and incapable of meeting the NHLBI's requirements without undergoing a costly overhaul. This software must be also compatible with the other NIH IRB management software to effectively achieve the institute's mission. Purpose and Objective: The NHLBI requires new IRB management software. The current system is outdated and incapable of meeting the NHLBI's requirements without undergoing a costly overhaul. This software must be also compatible with the other NIH IRB management software to effectively achieve the institute's mission. The NHLBI will be procuring iMedRIS Data Corporation's "Intergrated Research Information System (iRIS). Contractor Requirements: The contractor shall provide the following products/services to the NHLBI: 1. Unlimited user licenses to iRIS (IRB Assistant Enterprise Edition, IRB Assistant Enterprise Edition -Deputy Ethics Counselor, and Scientific Board modules) 2. Software support and helpdesk availability Monday through Friday from 8 AM to 5 PM EST (except for Government Holidays) during the course of the contract. 3. Standard system updates and enhancements Period of Performance: To be negotiated upon award. Justification: The determination by the Government to award a contract without providing for full and open competition is based upon the FAR 6.302-1, the equipment and services are only available from iMedRIS Data Corporation. This project will be modeled from the already established National Institute of Health IRB system established by the National Cancer Institute (NCI) and requires the collaboration of NHLBI with NCI IT staff. NCI IT staff is only trained to use iRIS. They do not have the expertise to implement NHLBI's IRB workflow processes using any other system. Additionally, iMedRIS has the only knowledge of the existing system; any other contractor tasked to perform these services would result in delays and duplication of costs. Furthermore, the NHLBI does not have the funds available to contract out the customization of iRIS and/or any other IRB management system. The iRIS system is proprietary to MedRIS Data Corporation. Regulatory Authority: This acquisition is conducted under the authority of FAR Part 6.302-1(a) 2.ii., Only one responsible source and no other supplies or services will satisfy agency requirements for follow-on contracts. Additional Information: Industry Classification (NAICS) Code is 541511, Custom Computer Programming Services and the Small Business Size Standard is $27.5 million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures. The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-76, effective August 25, 2014. The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), intends to negotiate and award a purchase order on a sole source noncompetitive basis to provide the Institutional Review Board (IRB) software, iRIS, for the Division of Intramural Research (DIR) to iMedRIS Data Corporation, 446 Missouri Court, Redlands, CA, 92373-8083. The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide the Institutional Review Board (IRB) software, iRIS, to iMedRIS Data Corporation, 446 Missouri Court, Redlands, CA, 92373-8083, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by October 16, 2014 at 12:00 p.m. EST. Responses must reference synopsis number HHS-NIH- NHLBI-CSB-HI-2015-008-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

Maintenance Services Contract for BD Biosciences Instrumentation

Department of Health and Human Services, National Institutes of Health | Published October 22, 2014  -  Deadline November 6, 2014
cpvs

Short Title: Maintenance Services Contract for Becton Dickinson Biosciences Flow Cytometry Instrumentation. Document Type: Presolicitation Notice Solicitation Number: N02NC52502-78 Posted Date: 10/22/2014 Response Date: 11/06/2014 3:30PM EST Classification Code: J066 - Maintenance, Repair, and Rebuilding of Equipment NAICS Code: 811219 - Other Electronic and Precision Equipment Repair and Maintenance. Business Size Standard: $20.5 M Contracting Office Address: Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive Room 1E140 Rockville, MD 20850. Description: The National Cancer Institute (NCI), Center for Cancer Research (CCR), Experimental Immunology Branch (EIB) plans to procure on a sole source basis with BD Biosciences, 2350 Qume Drive, San Jose, CA 95131-1807 maintenance services for the flow cytometry hardware and software systems. The equipment to be covered is: GSA CLINs: 1. BD FACSCalibur SN E5196 (4 color) - Open market 2. BD FACS Flow Supply System SN N1227 3. BD FACSARIA 3-Laser System, SN P22300031 4. BD FACSCALIBUR 4CLR System, SN E20200198 5. BD FACS Flow Supply System, SN N1813 Open market CLINs: 6. BD LSRII SPECIAL SN H47100178 7. BD Laser Component of SN H47100178, Sapphire 488-100 Blue Laser SN 3954 8. BD Laser Component of SN H47100178, 640-40 Red Laser SN 3955 9. BD Laser Component of SN H47100178, 594-50 Yellow Laser SN 5931 10. BD Laser Component of SN H47100178, Violet Laser 50 MW SN 3956 11. BD Laser Component of SN H47100178. UV 100mW Laser, SN 3953 This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1) for open market CLINs and FAR 8.405-6(a)(1)(i)(B) for GSA CLINs. Only one award will be made as a result of this solicitation. This will be awarded as a Firm Fixed Price (FFP) type contract. It has been determined that there is no opportunity to acquire green products or services under this contract. The EIB Flow Cytometry Facility provides basic research support to members of the EIB as well as to investigators throughout NCI, CCR. Basic research support is provided using multiple instruments manufactured by BD Biosciences and is provided 5 days per week to approximately 75 users. Each instrument supports multiple experiments each day, and each instrument is fully utilized. The experiments performed involve costly reagents, expensive animals, and multiple man-hours. When an instrument malfunctions, or does not operate optimally, these costly experiments are lost. Some experiments, if unable to be run on the instrument as scheduled, cannot be rescued. It is critical that this instrument remain in excellent operating condition at all times. It is also important that the quality of the results from this instrument be kept at a consistently high level. It is therefore necessary that all instrumentation operate in an optimal fashion, and that down time due to malfunctions and repair time be minimized. Because the nature of the equipment is highly experimental, the original equipment manufacturer, BD Biosciences, routinely designs and implements software and hardware improvements to the instrumentation. It is essential to the EIB that these revisions be installed in a timely fashion to maintain optimal performance. It is important that the instrument be kept current with software upgrades and product corrective actions. NCI also depends heavily on qualified telephone troubleshooting and technical assistance from the manufacturer's staff, including BD Biosciences field engineers. These assets are available only from BD Biosciences. Some of the instruments are uniquely designed for the laboratory; therefore the manufacturer is the only vendor familiar with service requirements of those instruments. SPECIFICATIONS/SERVICES TO BE PROVIDED: In order to maintain optimal performance and to minimize down time, the EIB requires maintenance services for the EIB flow cytometry instrumentation that includes: 1) Contractor shall be the direct provider of the services to be performed. 2) Contractor shall perform timely on-site repair by factory trained personnel and including OEM parts, labor and travel. All on-site repairs shall be performed at no additional cost to the Government. 3) All repairs shall be completed to conform to OEM standards and to the satisfaction of the equipment user. 4) In order to provide timely response, the contractor shall maintain an OEM trained local (Washington Metropolitan area) field service technical workforce, as well as an OEM spare parts inventory and a telephone consultation technical workforce. 5) Guaranteed on-site response time by field engineer of 48 hours or less for all repairs. 6) Contractor shall perform telephone support to include expert technical engineering advice, on all instruments. Such telephone support shall be provided on an immediate basis at no additional cost to the Government. 7) Two (2) preventative maintenance inspections per year performed by OEM trained field engineers and to include the OEM preventative maintenance parts kit for the equipment covered under this contract. 8) Contractor shall perform timely installation of all OEM software revisions and OEM component revisions, as well as re-installation of existing software and operating systems as required to repair instrumentation according to OEM standards. The contractor shall receive advance approval for the installation of all software updates and revisions from the Government. Defective software shall be replaced at no additional cost to the government. 9) Due to the complexity of the instrumentation, repairs may necessitate multiple engineers, multiple visits, and/or shipment and installation of multiple OEM parts and components to identify the exact nature of a problem. The contractor shall perform such trouble shooting in a timely fashion. Such troubleshooting services shall be provided by OEM trained personnel. Such troubleshooting services shall be provided at no additional cost to the Government. 10) Contractor shall furnish all required replacement parts and hardware component revisions, including shipping costs, with the exception of consumable parts as defined by the OEM. Parts shall be new or remanufactured to original equipment specifications. Contractor shall provide spare parts and upgraded components as necessary to repair equipment and maintain the equipment in optimal working order. When necessary for emergency repairs, contractor shall ship in stock parts and components by overnight delivery. Parts shall be new or remanufactured to original equipment specifications. If telephone consultation with factory trained field engineers identifies a spare part necessary for emergency repair, the contractor shall provide immediate shipment for overnight delivery for next day installation by qualified OEM trained field engineers. 11) The contractor shall perform emergency service repairs on an unlimited basis at no additional cost to the Government. In the case of an emergency, the contractor shall provide same day services at the NIH location where the equipment is located, by OEM trained field engineers for diagnosis and possible same day repair. SERVICE EXCLUSIONS: The contractor shall not be responsible for any repairs necessitated by abuse, neglect, vandalism, the use of unauthorized parts or reagents, Acts of God, fire or water. These repairs shall be the subject of a separate purchase order and shall not be performed under this contract. PERIOD OF PERFORMANCE: Performance shall be from January 19, 2015 to January 18, 2016. PERSONNEL QUALIFICATIONS: Personnel shall be trained by the manufacturer in the servicing of the equipment as covered by this contract. All primary service personnel shall have at least one backup support person with at least the same level of expertise on the equipment covered by this contract. PLACE OF PERFORMANCE: National Institute of Health (NIH) 10 Center Drive Bldg. 10, Room 4B43 Bethesda, MD 20892. This is not a solicitation for competitive quotations. However, if any interested party believes they can meet the above requirement, especially small businesses, they may submit a tailored statement of capabilities email. In addition, all responsible sources may submit a bid, proposal, or quotation which shall be considered by the NCI. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. All information must be received in the NCI contracting office on or before 3:30 PM EST on November 06, 2014. All questions must be in writing and can be emailed to Francisco Mendoza at francisco.mendoza@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the System for Award Management (SAM) www.sam.gov. No collect calls will be accepted. Please reference solicitation number N02NC52502-78 on all correspondences.

Maintenance Agreement for Five Spectra-Physics/Newport Lasers located in NHLBIs Division of Intramural Research (DIR) Laboratories

Department of Health and Human Services, National Institutes of Health | Published October 23, 2014  -  Deadline October 30, 2014
cpvs

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), on intends to negotiate and award a purchase order on a sole source noncompetitive basis to Newport Corporation, 1791 Deere Avenue, Irvine, CA, 92606 to provide maintenance services to five Spectra-Physics Newport Lasers located in Division of Intramural Research (DIR) Laboratories. PROCUREMENT: The contractor shall provide the following: • Onsite and/or offsite maintenance that includes parts, labor and travel excluding consumables on the following Division of Intramural Research (DIR) Spectra-Physics Newport Lasers: o MaiTai HP DS Serial #3349 o MaiTai HP DS Serial # 3356 o Maitai BB DS Serial # 1602-R1 o Millenia Xs S Serial # 851 o Insight DS Dual Laser Serial # 1131 BACKGROUND: The mission of the NHLBI Division of Intramural Research (DIR) is to perform robust scientific and clinical research leading to a better understanding of biology and clinical pathology. To attain this goal, we have built a strong basic science foundation and coupled it closely with innovative technology development and outstanding clinical research both at the NIH Clinical Center and in partnership with local hospitals. The purview of our research is broad, encompassing investigations into the basic principles of molecular, cellular, and organ-level biology and their relationship to disease. Some current areas of fundamental interest include single molecule structure; protein assembly; molecular and cell biology; cell signaling and motility; membrane trafficking; physiology; systems biology; engineering and technology development. Insights into disease mechanisms derived from basic studies form the basis for translational research into new diagnostic and therapeutic approaches. DIR investigators also conduct concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders. The Laboratories of Cardiac Energetics and the Optical Spectroscopy Section, part of the Systems Biology and the Biochemistry and Biophysics Centers of the National Heart, Lung, and Blood Institute of the National Institutes of Health, are involved in the study of advanced light microscopy methods to study biological processes. As part of the research, these labs require service maintenance contracts for lasers in their labs, which will enable their continued operation. A maintenance agreement is required to ensure the lasers are performing optimally to continue the valuable research of the laboratory. PURPOSE AND OBJECTIVE: This acquisition is for the purpose of procuring a multi-year maintenance agreement for five Spectra-Physics/Newport Lasers located in NHLBI's Division of Intramural Research (DIR) Laboratories. ANTICIPATED PERIOD OF PERFORMANCE: Base: November 13, 2014 through November 12, 2015 Option Period 1: November 13, 2015 through November 12, 2016 Option Period 2: November 13, 2016 through November 12, 2017 Option Period 3: November 13, 2017 through November 12, 2018 Option Period 4: November 13, 2018 through November 12, 2019 JUSTIFICATION: The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. Newport Corporation is the sole manufacturer of the Spectra-Physics aforementioned lasers. Newport Corporation does not allow third parties to provide maintenance on this equipment. REGULATORY AUTHORITY: This acquisition is conducted under the authority of 41 U.S.C. 253(c) as set forth in FAR Part 13.106-1 (b) (1), Soliciting from a single source not exceeding the simplified acquisition threshold, and is exempt from the requirements of FAR Part 6, Competition Requirements. ADDITIONAL INFORMATION: Industry Classification (NAICS) Code is 811219, Other Electronic and Precision Equipment Repair and Maintenance and the Small Business Size Standard is $20.5 Million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures. The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-77, effective October 14, 2014. The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide maintenance services to five Spectra-Physics Newport Lasers located in Division of Intramural Research (DIR) Laboratories to Newport Corporation, 1791 Deere Avenue, Irvine, CA, 92606, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by October 30, 2014 at 4:00 p.m. EST. Responses must reference synopsis number HHS-NIH-NHLBI-CSB-HI-2015-017-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@ nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

Multi-year Maintenance Agreement for the Flow Cytometry Cores BD LSRFortessa Flow Cytometry System

Department of Health and Human Services, National Institutes of Health | Published October 23, 2014  -  Deadline October 30, 2014
cpvs

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), on intends to negotiate and award a purchase order on a sole source noncompetitive basis to Becton, Dickinson and Company, 2350 Qume Dr., San Jose, CA, 95131-1812 to provide maintenance to the Flow Cytometry Core's BD Fortessa flow cytometry system. PROCUREMENT: The contractor shall provide the following: • Unlimited phone support and unlimited quick service within 24 hours, Monday-Friday, excluding government holidays • Complete support of the BD LSRFortessa (S/N H64717700086) with a High Throughput Sampler (S/N, U64770100406) • Complete support of the BD Biosciences software, FACSDiva, and computer workstation • Two Preventative Maintenances each year BACKGROUND: The mission of the NHLBI Division of Intramural Research (DIR) is to perform robust scientific and clinical research leading to a better understanding of biology and clinical pathology. To attain this goal, we have built a strong basic science foundation and coupled it closely with innovative technology development and outstanding clinical research both at the NIH Clinical Center and in partnership with local hospitals. The purview of our research is broad, encompassing investigations into the basic principles of molecular, cellular, and organ-level biology and their relationship to disease. Some current areas of fundamental interest include single molecule structure; protein assembly; molecular and cell biology; cell signaling and motility; membrane trafficking; physiology; systems biology; engineering and technology development. Insights into disease mechanisms derived from basic studies form the basis for translational research into new diagnostic and therapeutic approaches. DIR investigators also conduct concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders. The mission of the Flow Cytometry Core Facility at the National Heart, Lung and Blood Institute is to provide state of the art cell analysis using flow cytometry. It is necessary for the ongoing research in cardiology, hematology, and lung diseases. For the premier results in identifying cell populations determined by using lasers, and the highly complex and sensitive electronics of the BD Fortessa for cell analysis, it is necessary to have specially trained engineers from Becton Dickinson, the maker of the BD Fortessa, for service and routine timely maintenance to ensure the least amount of downtime of the cytometer. A maintenance contract will provide phone service and prompt service calls by the highly qualified BD engineers, to maximize the uptime and productivity for uninterrupted service to the Institute. PURPOSE AND OBJECTIVE: This acquisition is for the purpose of procuring a multi-year maintenance agreement for the Flow Cytometry Core's BD LSRFortessa flow cytometry system. ANTICIPATED PERIOD OF PERFORMANCE: Base: November 21, 2014 through November 20, 2015 Option Period 1: November 21, 2015 through November 20, 2016 Option Period 2: November 21, 2016 through November 20, 2017 Option Period 3: November 21, 2017 through November 20, 2018 Option Period 4: November 21, 2018 through November 20, 2019 JUSTIFICATION: The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. BD Biosciences is the sole manufacturer of the BD Fortessa and does not certify third party organizations to perform service on equipment. BD Biosciences is the only manufacturer that can supply spare or replacement parts which are unique to BD LSRFortessa flow cytometry system. REGULATORY AUTHORITY: This acquisition is conducted under the authority of 41 U.S.C. 253(c) as set forth in FAR Part 13.106-1 (b) (1), Soliciting from a single source not exceeding the simplified acquisition threshold, and is exempt from the requirements of FAR Part 6, Competition Requirements. ADDITIONAL INFORMATION: Industry Classification (NAICS) Code is 811219, Other Electronic and Precision Equipment Repair and Maintenance and the Small Business Size Standard is $20.5 Million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures. The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-77, effective October 14, 2014. The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide a multi-year maintenance agreement for the BD LSRFortessa flow cytometry system, 2350 Qume Dr., San Jose, CA, 95131-1812, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by October 30, 2014 at 12:00 p.m. EST. Responses must reference synopsis number HHS-NIH-NHLBI-CSB-HI-2015-014-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@ nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

Maintenance agreement for two JEM Transmission Electron Microscopes located in the Electron Microscopy Core Facility in the Division of Intramural Research (DIR).

Department of Health and Human Services, National Institutes of Health | Published October 24, 2014  -  Deadline October 31, 2014
cpvs

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), on intends to negotiate and award a purchase order on a sole source noncompetitive basis to JEOL USA Inc., 11 Dearborn Road, Peabody, MA, 01960-3862, to provide maintenance services to two JEM transmission electron microscopes located in the Electron Microscopy Core Facility in the Division of Intramural Research (DIR) Laboratories. PROCUREMENT: The contractor shall provide the following: • Comprehensive maintenance for the following instruments and accessories: o JEM-1400  JEM-1400 Transmission Electron Microscope (Serial # EM 18470093)  EM-11020 Common Specimen Holder  EM-21010 Common Specimen Holder  Seg Side Entry Goniometer for 1400,2100,1200F,2200FS,2500SE  Non-refrigerated Water to Water Recirc WW2HN2SK9 (Serial # HB22056) o JEM-1200EX  JEM-1200EX Transmission Electron Microscope (Serial # 158056-169)  SQH10 Quick Change Specimen Holder  EM-SEG10 Side Entry Goniometer  Heat Exchanger WW2HKN2R4SK8, W/50 Hal. Reservoir (Serial # HB22072) • The comprehensive maintenance shall include the following: o Ensuring all instruments and accessories are kept in good, working condition with minimal downtime o Two (2) preventive maintenance visits o Unlimited emergency service as required o Replacement and repair of all parts as required BACKGROUND: The mission of the NHLBI Division of Intramural Research (DIR) is to perform robust scientific and clinical research leading to a better understanding of biology and clinical pathology. To attain this goal, we have built a strong basic science foundation and coupled it closely with innovative technology development and outstanding clinical research both at the NIH Clinical Center and in partnership with local hospitals. The purview of our research is broad, encompassing investigations into the basic principles of molecular, cellular, and organ-level biology and their relationship to disease. Some current areas of fundamental interest include single molecule structure; protein assembly; molecular and cell biology; cell signaling and motility; membrane trafficking; physiology; systems biology; engineering and technology development. Insights into disease mechanisms derived from basic studies form the basis for translational research into new diagnostic and therapeutic approaches. DIR investigators also conduct concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders. The NHLBI Electron Microscopy Core Facility provides technical services, training and support for NHLBI/DIR investigators in all research projects that require structural information in the molecular to subcellular range at a higher level of resolution than can be obtained by photomicroscopy. In the past 4 years the Core supported 80 projects for 39 principal investigators. Roughly 50% of the data generated with the support of the Core consisted of electron micrographs taken with the JEM-1200EX and JEM-1400 transmission electron microscopes belonging to the Core. Over the past reporting year there have been 14 NHLBI PIs, Staff Scientists, Postdoctoral Fellows and Postbaccalaureate IRTAs who have been trained on and/or used either of these electron microscopes, in addition to the 4 Core staff members and a summer student. All indications are that the 1200EX and 1400, which are used most work days, will continue to be heavily used through the next 5+ years. A maintenance agreement is required to ensure the electron microscopes remain in good working condition. Neither the Electron Microscopy Core Facility nor the NHLBI can afford to have the Core's instruments down for an extended period of time as critical research heavily relies on the use of these instruments. PURPOSE AND OBJECTIVE: This acquisition is for the purpose of procuring a maintenance agreement for two JEM transmission electron microscopes located in the Electron Microscopy Core Facility in the Division of Intramural Research (DIR). ANTICIPATED PERIOD OF PERFORMANCE: Base: November 21, 2014 through November 20, 2015 Option Period 1: November 21, 2015 through November 20, 2016 Option Period 2: November 21, 2016 through November 20, 2017 Option Period 3: November 21, 2017 through November 20, 2018 Option Period 4: November 21, 2018 through November 20, 2019 JUSTIFICATION: The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. JEOL USA is the only source for comprehensive service contracts including routine maintenance, prompt emergency service and parts for the JEM-1200EX and JEM-1400 electron microscopes, which were manufactured by JEOL. JEOL holds proprietary rights to its service methods and repair instruments. REGULATORY AUTHORITY: This acquisition is conducted under the authority of 41 U.S.C. 253(c) as set forth in FAR Part 13.106-1 (b) (1), Soliciting from a single source not exceeding the simplified acquisition threshold, and is exempt from the requirements of FAR Part 6, Competition Requirements. ADDITIONAL INFORMATION: Industry Classification (NAICS) Code is 811219, Other Electronic and Precision Equipment Repair and Maintenance and the Small Business Size Standard is $20.5 Million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures. The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-77, effective October 14, 2014. The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide maintenance services to two JEM transmission electron microscopes located in the Electron Microscopy Core Facility in the Division of Intramural Research (DIR) Laboratories to JEOL USA Inc., 11 Dearborn Road, Peabody, MA, 01960-3862, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by October 31, 2014 at 12:00 p.m. EST. Responses must reference synopsis number HHS-NIH-NHLBI-CSB-HI-2015-016-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@ nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

Multi-year Maintenance Agreement for the Flow Cytometry Cores BD FACSAria II Special Cell Sorter System

Department of Health and Human Services, National Institutes of Health | Published October 28, 2014  -  Deadline November 4, 2014
cpvs

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), on intends to negotiate and award a purchase order on a sole source noncompetitive basis to Becton, Dickinson and Company, 2350 Qume Dr., San Jose, CA, 95131-1812 to provide maintenance to the Flow Cytometry Core's BD FACSAria II Special Cell Sorter System. PROCUREMENT: The contractor shall provide the following: Maintenance Services for the following equipment: 1. FACSAria II Special, Serial Number: P650033024 2. Laser Red Coherent Cube 637-150 3. Svc Cont SAPPHIRE 200 MW Blue laser 4. Svc Cont Laser Violet 405-100 5. Svc Lightwave XCYTE 60mw UV laser 6. Svc Cont SORP Coherent Sapphire 532-200 These maintenance services include: • BD FACSAria II Special Order System coverage with one computer workstation (excluding printers) for labor, travel expenses and parts (excluding consumables) • Two (2) Preventive Maintenance Inspections to be performed during a twelve-month period, including Two (2) Preventative Maintenance Kits • Software Revisions released during the agreement term • Unlimited service visits, Monday-Friday, excluding government holidays • Unlimited telephone support for instruments, reagents and applications • 48 hour emergency on-site service response time (Monday through Friday, excluding government holidays) BACKGROUND: The mission of the NHLBI Division of Intramural Research (DIR) is to perform robust scientific and clinical research leading to a better understanding of biology and clinical pathology. To attain this goal, we have built a strong basic science foundation and coupled it closely with innovative technology development and outstanding clinical research both at the NIH Clinical Center and in partnership with local hospitals. The purview of our research is broad, encompassing investigations into the basic principles of molecular, cellular, and organ-level biology and their relationship to disease. Some current areas of fundamental interest include single molecule structure; protein assembly; molecular and cell biology; cell signaling and motility; membrane trafficking; physiology; systems biology; engineering and technology development. Insights into disease mechanisms derived from basic studies form the basis for translational research into new diagnostic and therapeutic approaches. DIR investigators also conduct concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders. The mission of the Flow Cytometry Core Facility at the National Heart, Lung and Blood Institute is to provide state of the art cell analysis using flow cytometry. It is necessary for the ongoing research in cardiology, hematology, and lung diseases. For the optimal results in identifying cell populations determined by using lasers, and the highly complex and sensitive electronics of the BD FACSAria for cell sorting, a maintenance contract must be in place to have specially trained engineers for service and routine timely maintenance to ensure the least amount of downtime of the cell sorter. A maintenance contract must provide phone service and prompt service calls by highly qualified engineers, to maximize the uptime and productivity for uninterrupted service to the Institute PURPOSE AND OBJECTIVE: This acquisition is for the purpose of procuring a multi-year maintenance agreement for the Flow Cytometry Core's BD FACSAria II Special Cell Sorter System. ANTICIPATED PERIOD OF PERFORMANCE: Base: December 18, 2014 through December 17, 2015 Option Period 1: December 18, 2015 through December 17, 2016 Option Period 2: December 18, 2016 through December 17, 2017 Option Period 3: December 18, 2017 through December 17, 2018 Option Period 4: December 18, 2018 through December 17, 2019 JUSTIFICATION: The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. BD Biosciences is the sole manufacturer of the BD FACSAria II and does not certify third party organizations to perform service on equipment. BD Biosciences is the only manufacturer that can supply spare or replacement parts which are unique to BD FACSAria II Special Cell Sorter System. REGULATORY AUTHORITY: This acquisition is conducted under the authority of the Federal Acquisition Regulations (FAR) Subpart 13.106-1(b) Soliciting from a single source, only one responsible source and no other supplies or services will satisfy agency requirements. ADDITIONAL INFORMATION: Industry Classification (NAICS) Code is 811219, Other Electronic and Precision Equipment Repair and Maintenance and the Small Business Size Standard is $20.5 Million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures FAR subpart 15-Contracting by Negotiation at an amount exceeding the simplified acquisition threshold ($150,000). The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-77, effective October 14, 2014. The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide a multi-year maintenance agreement for the BD FACSAria II Special Cell Sorter System, 2350 Qume Dr., San Jose, CA, 95131-1812, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 04, 2014 at 12:00 p.m. EST. Responses must reference synopsis number HHS-NIH-NHLBI-CSB-HI-2015-020-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@ nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

Purchase of two (2) EM CCD Andor 888 cameras for single molecule tracking

Department of Health and Human Services, National Institutes of Health | Published October 29, 2014  -  Deadline November 19, 2014
cpvs

The National Cancer Institute (NCI), Center for Cancer Research (CCR), Laboratory of Receptor Biology and Gene Expression (LRBGE), plans to procure on a sole source basis two (2) Andor Du-888U3-CSO-#BV (Vis Optimized) iXON Ultra 1Kx1K EM CCE cameras with 13 um pixels, 26fps full frame, includes I/O cable from BioVision Technologies, Inc., 64 E. Uwchlan Avenue #273, Exton, PA 19341, USA. This process will be processed in accordance with simplified acquisitions procedures as stated in FAR Part 13 13.106-1(b)(1) and is exempt for the requirements of FAR Part 6. The North American Industry Classification System code is 334516 and the business size standard is 500. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. It has been determined there are no opportunities to acquire green products or services for this procurement. Delivery will be 30 days from date of award. The NCI/CCR LRBGE laboratory's research program concerns the elucidation of mechanisms involved in the regulation of genetic expression in eucaryotic cells and the identification of genes and regulatory processes involved in modulated states of expression during oncogenesis. The LRBGE plans to purchase two high-end Andor iXON Ultra EM CCD cameras for the simultaneous two-channel single-molecule tracking in living cells. The cameras will be used to upgrade the existing single molecule tracking system that currently allows tracking of only one color. Single molecule tracking is a state-of-the art method for the biophysical quantification of the behavior of the transcription factors on their DNA targets. Thus, LRBGE are conducting a number of high-end technically demanding experiments that requires the top performance from its cameras. Next, a sole source is intended for the purchase of the Andor iXon Ultra EM CCD cameras from BioVision Technologies, as it will help with further development of NCI/CCR Optical Microscopy Core's knowledge about the transcription regulation of the cancer cells dual-color tracking of single molecules will be used to probe the specific and non-specific interactions of transcription factors on the same promoter in living cells. NCI feels BioVision Technologies equipment is uniquely qualified based on its performance characteristics and quality of the hand -picked piece of equipment (Andor 888) that's required for the integrity of the experiments conducted by LRBGE research group. In addition, BioVision replacement parts (the cameras) are compatible with NCI's existing equipment, and a change would be disruptive to the science. The purchase will allow for the successful continuation of on-going experiments on single molecule tracking. Salient characteristics of the Andor iXON Ultra EM CCD Camera are as follows: a. 30MHz and 20 MHz readout modes (EM channel) b. Frame rate maximum of 25.7 fps (full resolution - 1024 x 1024) c. Optically Centered Crop Mode offering 697 frames/sec from 128 x 128 ROI d. USB 3.0 interface e. Data conversion to Electrons or Photons, either Real-Time or Post-Processing f. Spurious Noise filter that is either Real-Time or Post-Processing g. OptAcquire - Push Button acquisition mode optimization h. Direct Data Access via separate CameraLink output i. Ring Mode - Up to 16 pre-defined exposure times can be uploaded onto the camera FPGA, facilitating instant exposure switching upon acceptance of external (TTL) or software trigger j. ‘Temperature Compensated' linear and calibrated EM Gain scale - i.e. calibration holds at all selected cooling temperatures k. Advanced Photon Counting mode - including Real-Time and Post-Acquisition definition of accumulated block size l. Hardware (FPGA) generated timestamp with 10 ns accuracy This is not a solicitation for competitive quotations. However, if any interested party especially a small business, believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on, November 19, 2014. No electronic capability statements will be accepted (i.e. email or fax); an original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed (240) 276-5401 or emailed to Gwennifer Epps, Contracting Officer at ge50d@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA), through sam.gov. No collect calls will be accepted. Please reference solicitation number N02RC52504-83 on all correspondence.

Eclipse RapidArc Planning License for Varian Eclipse Treatment Planning System

Department of Health and Human Services, National Institutes of Health | Published October 29, 2014  -  Deadline November 12, 2014
cpvs

Contracting Office Address Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 9609 Medical Center Drive, Room 1E626, Bethesda, MD 20892, UNITED STATES Description The National Cancer Institute (NCI), Center for Cancer Research (CCR), Radiation Oncology Branch (ROB), plans to procure on a sole source basis RapidArc Planning license for its Varian Eclipse Treatment Planning System (TPS) to better understand the role of radiation in the treatment of disease from Varian Medical Systems, 2250 Newmarket Parkway, suite 120, Marietta, GA, 30067, UNITED STATES. This acquisition will be processed in accordance with simplified acquisition procedures as stated in FAR Part 13.106-1(b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 423430 and the business size standard is 100 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. It has been determined there are no opportunities to acquire green products or services for this procurement. The Radiation Oncology Branch of the CCR treats cancer patients with radiation according to approved clinical protocols and performs research to better understand the role of radiation in the treatment of disease. The current requirement of the ROB is for Eclipse RapidArc Planning License. ROB has utilized the Eclipse Treatment Planning System (TPS) in order to plan radiation treatments for the vast majority of its patients. This system is manufactured, distributed and serviced by Varian Medical Systems. Eclipse is built around a base system that provides a graphical user interface for data input, a calculation engine for determining dose distribution volumes and a display and output components for visualizing the results and generating printed copies which act as written prescription verification. Eclipse is thoroughly integrated into Varian's ARIA patient management system, where all treatment parameters and results are stored for each patient. The Government owns both the ARIA system and six Eclipse treatment planning workstations (validated hardware plus software). In addition to the base TPS, Varian also offers additional software modules that extend the systems capabilities. One of the features of Varian RapidArc and TrueBeam accelerators is the ability to perform RapidArc radiation treatments. For a RapidArc treatment, the accelerator gantry rotation is dynamically controlled along with the radiation intensity and the shape of the radiation field, so as to precisely deliver the planned radiation dose distribution to the target volume while at the same time providing the maximum protection to uninvolved structures. Treatment planning for RapidArc delivery requires a specialized software module for Eclipse that will take in information about the target location and shape, along with the locations and shapes of all designated critical normal structures and the physician's intent and generate a treatment plan that provides the optimum solution to the problem which the physician can then use as the basis for prescription. The module also generates all of the accelerator-specific information related to the plan and passes it to the ARIA Patient Management System, so that it can be recalled to the treatment console and used to treat the patient. Varian Medical Systems (VMS) is the premier manufacturer of radiation therapy equipment and support equipment in the United States. The Radiation Oncology Branch, NCI owns one Varian linear accelerator and is in the process of installing a second one. Additionally, ROB owns VMSs ARIA Patient Management System, Eclipse treatment Planning Systems. ROB has considerable time and money invested in these systems. The RapidArc Planning module has been developed by Varian Medical Systems as an integral extension of both the Eclipse Treatment Planning System and the RapidArc and TrueBeam accelerator systems. Varian Medical Systems is the sole vendor capable of developing this integrated package. ECLIPSE is a proprietary software system developed by VMS and is protected by both copyright and patent. VMS has also certified both Eclipse and this module with the FDA as medical devices through the 510(k) approval process. Varian solely developed this software and is its sole distributor. Additionally, installation of any third-party software modules into the Eclipse TPS will invalidate existing service agreements. This notice is not a request for competitive quotation. However, if any interested party, especially small businesses, believes it can meet the above requirement, it may submit a capability statement, proposal, or quotation, which shall be considered by the agency. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow NCI to determine if the party can perform the requirement. Responses must be received in the contracting office by 4:00 PM EST, on November 12, 2014. All responses and questions must be in writing and faxed 240-276-5401 or emailed to Kimesha Leake, Contract Specialist via electronic mail at kimesha.leake@nih.gov. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. In order to receive an award, contractors must be registered and have valid certification in the System for Award Management (SAM) through sam.gov. Reference: N02RC52503-24 on all correspondence.

Senior-Level Acquisitions Support Services

Department of Health and Human Services, National Institutes of Health | Published November 4, 2014  -  Deadline November 13, 2014
cpvs

Pre-solicitation Non-competitive (Notice of Intent) Synopsis INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA) on behalf of the Information Technology and Applications Center (ITAC) intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to Dennis E. Black, LLC., 3 Locust Drive, Thurmont, MD 21788 for Senior-Level Acquisitions Support Services. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541611 with a Size Standard of $14,000,000.00. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-74 effective November 1, 2014. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($150,000). STATUTORY AUTHORITY This acquisition is for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5-Test Program for Certain Commercial Items, section 4202 of the Clinger-Cohen Act of 1966) and the statutory authority of FAR 6.302-1-Only one responsible source and no other supplies or services will satisfy agency requirements 41 U.S.C. 253(c)(1). DESCRIPTION OF REQUIREMENT Background The National Institutes of Health (NIH) is an agency within the U.S. Department of Health and Human Services (HHS) and consists of 27 separate Institutes and Centers (ICs) principally located in the Washington-Baltimore Metropolitan Area. NIH's mission is science in pursuit of fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to extend healthy life and reduce the burdens of illness and disability. The goals of the agency are as follows: 1) foster fundamental creative discoveries, innovative research strategies, and their applications as a basis to advance significantly the Nation's capacity to protect and improve health; 2) develop, maintain, and renew scientific human and physical resources that will assure the Nation's capability to prevent disease; 3) expand the knowledge base in medical and associated sciences in order to enhance the Nation's economic well-being and ensure a continued high return on the public investment in research; and 4) exemplify and promote the highest level of scientific integrity, public accountability, and social responsibility in the conduct of science. To accomplish its mission, NIH conducts research in institute laboratories; sponsors research by scientists in universities, medical schools, hospitals, and research institutions around the world; supports research training, and supports biomedical information knowledge management and communication. The National Heart, Lung, and Blood Institute (NHLBI), an NIH IC, provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. The NHLBI stimulates basic discoveries about the causes of disease, enables the translation of basic discoveries into clinical practice, fosters training and mentoring of emerging scientists and physicians, and communicates research advances to the public. It creates and supports a robust, collaborative research infrastructure in partnership with private and public organizations, including academic institutions, industry, and other government agencies. The Institute collaborates with patients, families, health care professionals, scientists, professional societies, patient advocacy groups, community organizations, and the media to promote the application of research results and leverage resources to address public health needs. The NHLBI also collaborates with international organizations to help reduce the burden of heart, lung, and blood diseases worldwide. The Information Technology and Applications Center (ITAC) provides IT support services and application development to the NHLBI and awards several millions of dollars of contracts each year for these services. Purpose and Objectives The objective of this SOW is to acquire senior-level acquisition services to support the NHLBI's ITAC (i.e., the Customer) in (1) processing NHLBI's complex enterprise-wide Information Technology (IT) acquisitions through the entire acquisition life-cycle including planning, evaluation, and post-award reporting and (2) assisting the Customer in establishing process, templates, and training on the NHLBI acquisition process. Period of Performance The period of performance of this requirement shall not execeed six (6) months from time of award for a minimum/maximum of 520 hours. Project Description The Contractor shall provide senior-level acquisition support services to the Customer as specified below. TASK AREAS Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government, as needed to perform Task Assignments at the direction of the Contracting Officer's Representative (COR) in the following Task Areas; Task Area 1 - Status Reports The Contractor shall meet with the COR on an as-required basis to provide verbal reports on the status of individual task assignments. Task Area 2- Acquisition Requirements Gathering The Contractor shall assist the Customer in determining the scope of work for individual acquisition requirements and to recommend appropriate methods of acquisition and types of acquisition mechanisms to be used to meet a specific set of requirements. Task Area 3 - Prepare Draft Acquisition Documents The Contractor shall prepare a wide variety of draft acquisition documents specific to ITAC acquisitions, including statements of work and specifications, costs estimates, and other supporting documents required to be included in an acquisition record. Task Area 4 - Gather General Information and Prepare Reports The Contractor shall conduct studies and analyses as required to monitor the contracted programs and projects of the Customer. The Contractor shall prepare reports to meet the Customer's staff requirements on an as needed basis. Task Area 5 - Review and Edit Licensing Agreements The Contractor shall review and edit complex intellectual property transactions to ensure compliance with the FAR and other Federal law. Included in such tasks are (1) reviewing and editing software license agreements to protect the Customer's interests, and (2) coordinating revisions with the Customer‘s technical and management staff members and NHLBI the Office of Acquisitions (OA). This Task Area shall include (1) reviewing U.S. copyright law and other statutes that affect the rights of the parties under a license agreement, (2) reviewing current NIH policy on negotiating and approving license agreements, (3) ensuring that terms and conditions are negotiated that protect the Government's interests under license agreements, and (4) developing draft guidance, including tutorials, for technical and mangement staff in reviewing and negotiating license agreements for software and other intellectual property. Task Area 6 - Develop Acquisition Provisions and Guidelines The Contractor shall assist the Customer in understanding NIH-wide acquisition provisions and guidelines relative to the implementation of the Information Security requirements of the Federal Information Security Act of 2002 (FISMA), the Physical Security requirements of Homeland Security Presidential Directive (HSPD)-12, and other Federal policies and guidance affecting the acquisition of IT resources. Task Area 7 - Provide Instruction and Training on Acquisition-Related Topics The Contractor shall provide instruction and training to the Customer's staff members on an as needed basis on various acquisition-related topics. Task Area 8 - Review and Improvements of Acquisition Related Templates Develop templates for reuse of key acquisitions documents such as the Performance Work Statement (PWS), Sole Source Justification/JOFOC, etc. Develop checklists for acquisitions specific to ITAC to help guide ITAC federal staff through the acquisition process. Provide guidance on usage of the Independent Government Cost Estimate (IGCE) and work with the government to determine best practices for using IGCE's in the ITAC acquisition environment. Help develop estimation templates based on the existing ITAC BPA costs that can be tailored for use for non-BPA contracts. Task Area 9 - Other Services The Contractor shall perform other Task Assignments relating to the scope, but not otherwise specified above, as directed by the COR to support the Customer. Task Area 10 - Phase-Out Plan In the event the Government competes the requirements of this SOW and prior to completion of this Task Order's period of performance, the Contractor shall, at the Government's option, provide the Government with a Phase-Out Plan that shall ensure an orderly and successful transition of the remaining task assignments to a successor contractor should the incumbent Contractor not be selected during the competition. As part of the Phase-Out Plan, the Contractor shall adequately train the successor contractor's employees following any competition of the requirements specified in this SOW. Other Important Considerations In order to successfully perform all of the work requirements specified above, a contractor must possess, at a minimum, senior-level experience and expertise in the following: (1) an in-depth working knowledge of Federal and, in particular, NIH policies and procedures for Information and Physical Access Security as they pertain to the acquisition of complex IT resources; (2) extensive subject matter expert knowledge and experience in processing the award of complex enterprise-wide IT acquisitions through the entire acquisition life-cycle in a Federal agency with a scientific-focused mission; (3) extensive subject matter expert knowledge and experience in reviewing and negotiating complex commercial licensing agreements for IT resources to ensure compliance with the FAR and other Federal law; and (4) extensive subject matter expert knowledge and experience in developing and implementing NIH-wide Information and Physical Access Security acquisition procedures and provisions. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION The Customer conducted market research pursuant to the procedures prescribed at FAR 10.002 to determine if other commercial sources are available with the combination of senior-level experience and expertise required to successfully perform all of the work specified above. The determination was made that the Government's requirements can be met by acquiring the required subject matter expertise that is customarily available in the commercial marketplace. The techniques used by Customer's program staff in conducting the market research included (1) contacting knowledgeable sources regarding existing capabilities in the marketplace to meet the Government's requirements, and (2) reviewing lists of alternative sources that provide subject matter expertise in complex Federal IT acquisitions to determine if other sources are available in the open market, including the GSA Federal Supply Schedule. The Customer examined the availability of certified small business concerns that could successfully perform all of the work requirements specified above. Dennis E. Black, LLC is a Veteran Owned Small Business and is currently registered in the Federal System of Award Management (SAM) (DUNS No. 117080098). As a result of the market research conducted by the Customer's program staff, Dennis E. Black, LLC, is the only source identified that can provide the unique combination of senior-level experience and subject matter expertise to successfully perform all of the work requirements. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by 12:00PM EST on November 13, 2014 and must reference number NHLBI-CSB-(HL)-2014-025-JEF. Responses may be submitted electronically to Jenn Frazer at jenn.frazier@nih.gov or by U.S. mail to the National Heart, Lung, and Blood Institute, Office of Acquisitions, COAC Services Branch,6701 Rockledge Drive, Room 6145 Bethesda, MD 20892-7902, Attention: Jenn Frazier. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."

MAINTENANCE SERVICE FOR TWO GENETIC ANALYZERS FOR TRANSFUSION MEDICINE

Department of Health and Human Services, National Institutes of Health | Published November 4, 2014  -  Deadline November 14, 2014
cpvs

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a one year firm-fixed price purchase order to Life Technologies Corporation (Large Business) Carlsbad, CA 92008-7321 on a sole source basis to procure a preventative maintenance contract for two genetic analyzers that are used in the Department of Transfusion Medicine protocols. Life Technologies Corporation is the only known vendor/service provider that manufactures the ABI Prism 3730XL DNA Analyzer, and 3500xL Genetic Analyzer instruments. Life Technologies Corporation does not authorize any third-party service provider to perform maintenance and repair on Life Technologies instruments. Life Technologies Corporation maintains "Intellectual Property" rights to its collection software and service tools software. Third party resellers and service providers are strictly prohibited from accessing, using or selling software. This acquisition is being conducted under the authority of the FAR Subpart 13.106-1(b). Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Each response should include the following Business Information: a. DUNS. b. Company Name, address, POC, Phone and Email address c. Current GSA Schedules or NAICS codes appropriate to this Award. d. Type of Company (i.e., small business, 8(a), woman owned, hubZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1 e. Capability Statement Comments to this announcement, referencing this posting number, may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Malinda Dehner, Contract Specialist, dehnerm@cc.nih.gov by the due date and time marked in this notice.

Purchase and Installation of sixteen (16) -80 Vario (Model1539) Temperature Controlled Liquid Nitrogen Freezers, and four hundred and sixteen (416)13/2 Stainless Steel Vertical Freezer Rack with Locking Rods

Department of Health and Human Services, National Institutes of Health | Published November 4, 2014  -  Deadline November 21, 2014
cpvs

Description of Requirement The National Cancer Institute (NCI), Center for Cancer Research (CCR), Office of the Directory (OD), plans to procure on a sole source basis sixteen (16) Vario 1539 Temperature Controlled Liquid Nitrogen Freezers; and four hundred and sixteen (416) 13/2 Stainless Steel Vertical Freezer Rack with Locking Rod from Cryo, 7905-A Airpark Road, Gaithersburg, MD 20879, USA. This acquisition will be conducted under the procedures for acquiring commercial items authorized in FAR Part 12 and under the authority to use simplified procedures for commercial requirements as provided in FAR 13.501. The North American Industry Classification System code is 424690 and the business size standard is 500 employees. Only one award will be made as a result of this solicitation. This will be awarded as a firm-fixed-price type contract. It has been determined there are no opportunities to acquire green products or services for this procurement. The Center for Cancer Research (CCR) is an intramural scientific Division of the National Cancer Institute (NCI). The CCR continually performs scientific experiments that generate biological samples that contain cellular components, extracts, DNA/RNA, proteins, serum, and other biological components. These samples require a constant ultra-low temperature of -80 degrees Celsius to preserve their integrity. CCR has a bio-repository facility space available to house ultra-low cryogenic freezers. To keep sample integrity risk to a minimum, CCR must utilize cryogenic freezers that can maintain -80 degrees Celsius using liquid nitrogen as a cooling/fuel source rather than electricity. Next, a sole source is intended for the purchase and installation of (16) ultra-low temperature cryogenic freezers into a biological repository space that has been prepared to receive the freezers. The project also includes the procurement and installation of (416) vertical freezer racks that will be placed inside the freezers to house the biological samples that need such storage. Cryo Express is the only known supplier for the MVE Vario 1539 liquid nitrogen fueled freezer that is required. The salient characteristic for this tank is the fact that it can maintain a constant temperature of -80 degrees Celsius as opposed to the other liquid nitrogen fueled cryogenic freezers that maintain a temperature in the -150 degree Celsius range. The ability to modulate the nitrogen feed to maintain a -80 degree environment is critical. Many companies offer liquid nitrogen fueled cryogenic freezers, but none offer the modulation capability to maintain a -80 temperature set point as the MVE Vario 1539. In addition, the MVE VariōTM Series is the new innovative and energy efficient alternative for ultra-low temperature to cryogenic storage. The completely dry sample storage area will maintain a user-defined temperature anywhere between -20°C and -150°C. The MVE Variō Series significantly reduces the possibility of sample contamination via contact with LN2 while providing the safety margin and consistent temperature profile, even with the lid open, that is associated with LN2 based cryogenic storage. The MVE Variō Series is able to provide all of this with less than 1% of the power consumption and approximately 70% overall operating cost savings when compared to the leading mechanical freezers. Thus based on the unique features and specifications of the Vario 1539, it is the only item that can satisfy the NIH/CCR need for liquid nitrogen fueled -80 degree Celsius freezers. Specifications of Vario 1539 are as follows: 1. User defined temperature within -20 °C to -150 °C operating range 2. Completely dry storage area 3. Consistent temperature profile, unaffected by lid openings 4. Integral Turn Tray for Easy Rack Retrieval (design provides significant ergonomic advantage for removing heavy racks from freezer) 5. No recovery time needed 6. LN2 consumption: 9 L/day 7. Power consumption, 8 W 8. Improved sample processing time due to rapid temperature recovery upon introduction of warm racks or samples 9. Safety margin (LN2 supply removed until -60 °C) a. 4 days from -80 °C b. 9 days from -150 °C 10. 72 hour rechargeable battery backup option 11. Significant ambient noise reduction 12. Password protected controller 13. Alarms and Monitoring a. 4-20 mA temperature output b. Dual chamber temperature sensors c. Event Log contains up to 30,000 unalterable, time stamped events (approx. 10 years) d. 15 user defined audio/visual alarms e. High temperature, lid open, and stuck valve discrete alarms f. RS-485 communication for remote monitoring or control 14. Affordable and simple preventative maintenance a. No expensive compressors to replace b. Approximately 70% operating cost savings compared to leading mechanical freezers (-80 °C) Based on power consumption and LN2 costs 15. Convertible asset, Can be field retrofitted to be a traditional LN2 freezer 16. Green: Environmentally Friendly a. Less than 1% of the electricity consumption compared to leading mechanical freezers (-80 °C) b. No additional HVAC required due to negligible to negative thermal load c. No ozone depleting chlorofluorocarbon (CFC) or hydrofluoric carbon (HFC) refrigerants d. Zero CO2 emissions e. No disposal issues; over 90% recyclable Critical Required Features - The following features are critical and must be provided: 1. Variable Operating Temperature of -20c to -150c throughout the storage space for long term stable storage. 2. Must operate with liquid nitrogen as its cooling method as the freezers are being connected to a liquid nitrogen source 3. The unit cannot utilize compressors for cooling. 4. Integral Turn Tray for Easy Rack Retrieval 5. UL Listed 6. 100% Anhydrous Vapor Phase Storage 7. Folding Stainless Steel Step 8. All Stainless Steel Construction for Maximum Equipment Life 9. Locking Lid Tab 10. Stand Alone Control Unit for Ease of Service Delivery and Installation The contractor shall deliver the item within 60 days after award to NIH/NCI Bethesda, Maryland 20892. The Contractor will be provided with the complete mailing address and point of contact. Upon delivery, contractor must notify the NCI Contracting Officer's Representative (COR) to schedule the installation date and time. To be carried out by the manufacturer and shall occur within approximately one week of delivery. Payment Payment shall be made after delivery, installation, and successful operation of all sixteen (16) (model 1539) Temperature controlled Liquid Nitrogen freezers and four hundred and sixteen (416) stainless steel vertical freezer rack with locking rods. Payment authorization requires submission and approval of an invoice to the NCI COR and NIH Commercial Accounts. This is not a solicitation for competitive quotations. However, if any interested party especially a small business, believes they can meet the above requirement, they may submit a statement of capabilities. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. An original and one copy of the capability statement must be received in the NCI Office of Acquisitions on or before 11:00 AM EST on, November 21, 2014. No electronic capability statements will be accepted (i.e. email or fax); an original and one copy must be sent to the NCI Office of Acquisitions at the address stated above. All questions must be in writing and can be faxed (240) 276-5401 or emailed to Gwennifer Epps, Contracting Officer at ge50d@nih.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA), through sam.gov. No collect calls will be accepted. Please reference solicitation number N02RC52505-83 on all correspondence.

Custom Bred Mice

Department of Health and Human Services, National Institutes of Health | Published November 6, 2014  -  Deadline November 13, 2014
cpvs

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA), on intends to negotiate and award a purchase order on a sole source noncompetitive basis to The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, 04609-1500, to provide custom bred mice needed to test the use of multi-photon microscopy in tissue observation for the Systems Biology Center (SBC) of the Division of Intramural Research (DIR). PROCUREMENT: The contractor shall rederive two strains, Flk1GFP and Flt1-tdsRed, into their maximum barrier breeding facility using C57BL/6J oocyte donors. Breeding colonies will be established as Heterozygous x Wildtype or reciprocal matings. Once the colonies are established, there will be weekly shipments of 3 Het Flt1-tdsRed mice and 2 Het Flk1GFP mice at 8 weeks of age over the period of 97 weeks. Prior to shipment, the contractor will genotype the mice by performing tail snips and running PCR tests prior to ensure the proper strain is shipped. The first shipment of 3 Het Flt1-tdsRed mice and 2 Het Flk1GFP mice should occur approximately 9 months after the delivery of donor males to contractor's facilities. The colonies will be removed one month after the final shipment. BACKGROUND: The mission of the NHLBI Division of Intramural Research (DIR) is to perform robust scientific and clinical research leading to a better understanding of biology and clinical pathology. To attain this goal, we have built a strong basic science foundation and coupled it closely with innovative technology development and outstanding clinical research both at the NIH Clinical Center and in partnership with local hospitals. The purview of our research is broad, encompassing investigations into the basic principles of molecular, cellular, and organ-level biology and their relationship to disease. Some current areas of fundamental interest include single molecule structure; protein assembly; molecular and cell biology; cell signaling and motility; membrane trafficking; physiology; systems biology; engineering and technology development. Insights into disease mechanisms derived from basic studies form the basis for translational research into new diagnostic and therapeutic approaches. DIR investigators also conduct concept-based clinical studies in the areas of interventional and surgical cardiology; pulmonary medicine; sickle cell anemia; bone marrow transplant; and hematologic disorders. The Systems Biology Center (SBC) of the Division of Intramural Research of the National Heart Lung and Blood Institute is involved in the study of the structure/function relationships of different mouse tissues. Detailed examine of tissue morphology (i.e., the basic layout of a tissue's structural components), coupled with monitoring of cellular metabolism, will allow the lab to understand how different cell types respond to perturbation. With this information, the lab can apply its findings to disease states, where changes in overall structure might drastically impact a tissue's physiological function. SBC plans to investigate the morphological and functional characteristics of mouse skeletal muscle, kidney, and brain. Concurrent with these physiological measurements will be the continued development of the multi-photon microscopy motion tracking technique, which enables scientific staff to follow real-time metabolic changes in the living mouse. Multi-photon microscopy is a relatively new tool that uses pulsed infrared light to image metabolism deep within intact tissues in living animals to levels of resolution that no other technique can approach. In particular, this study will examine fluorescent characteristics in tissues of live, anesthetized mice and on tissues harvested from mice to determine the optical and experimental parameters necessary to use this technique on live animals in more complicated experiments in the future. Continued development of this technique is important for future studies of many different biological processes applicable to human disease. Fluorescently-labeled protein can give us structural information about the small functional components of cells within tissue, in vivo. In this study, the SBC will specifically emphasize procedures for imaging many aspects of muscle, kidney, and brain. Though SBC's staff has gained experience in imaging skeletal muscle and has improved their motion tracking software immensely, they have yet to examine physiological perturbations to the muscle (i.e., exercise stimulation) and have just begun studies on the kidney and brain. Therefore, the overall goal of this protocol is broad-spectrum in vivo imaging of mouse tissues, with a specific emphasis on tracking metabolic changes in response to insult. The breeding project is for a mouse that expresses channelrhodopsin in the cell membranes of heart and skeletal muscle. Channelrhodopsin is a light gated channel that opens when exposed to blue light. Opening this channel in the membrane of heart and skeletal muscle causes muscle contraction to occur. Under the microscope, the user can control when and where the muscle is exposed to blue light thus allowing the user to spatially and temporally control muscle contraction in groups of fibers or even single fibers. This technique will allow SBC's staff to study mitochondrial energy metabolism without the difficulties associated with motion and swelling caused by whole muscle stimulation. Additionally, lab staff will be able to evaluate the blood flow response to contraction of selected regions of muscle. PURPOSE AND OBJECTIVE: This acquisition is for the purpose of procuring custom bred mice needed to test the use of multi-photon microscopy in tissue observation for the Systems Biology Center (SBC) of the Division of Intramural Research (DIR). ANTICIPATED PERIOD OF PERFORMANCE: To be negotiated upon award. JUSTIFICATION: The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. The Jackson Laboratory is the only source capable of fulfilling the government's requirement. The SBC has used mice rederived by The Jackson Laboratory for its past experiments and must continue to obtain mice from The Jackson Laboratory in order to maintain consistency in research. The use of other sources would invariably cause variation in this ongoing research and even the slightest variation in the breeding process could skew the lab's data. The success of this research is contingent upon maintaining consistency in the breeding process. REGULATORY AUTHORITY: This acquisition is conducted under the authority of 41 U.S.C. 253(c) as set forth in FAR Part 13.106-1 (b) (1), Soliciting from a single source not exceeding the simplified acquisition threshold, and is exempt from the requirements of FAR Part 6, Competition Requirements. ADDITIONAL INFORMATION: Industry Classification (NAICS) Code is 112990, All Other Animal Production and the Small Business Size Standard is $0.75 Million. This acquisition is conducted under the procedures as prescribed in FAR subpart 12-Acquisition of Commercial Items and FAR subpart 13-Simplified Acquisition Procedures. The solicitation document, the incorporated provisions and clauses are those in the Federal Acquisition Circular 2005-77, effective October 14, 2014. The determination by the Government to award a purchase order on a sole source noncompetitive basis to provide custom bred mice needed to test the use of multi-photon microscopy in tissue observation for the Systems Biology Center (SBC) of the Division of Intramural Research (DIR) to The Jackson Laboratory, 600 Main Street, Bar Harbor, ME, 04609-1500, is based upon the market research conducted in accordance with one or more of the techniques specified in FAR Part 10-Market Research, Subpart 10.002(b)(2). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 13, 2014 at 12:00 p.m. EST. Responses must reference synopsis number HHS-NIH-NHLBI-CSB-HI-2015-027-CDB, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6121A, Bethesda, Maryland 20892-7902, Attention: Chris Bocus. Response may be submitted electronically to chris.bocus@ nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

Service Contract for Amnis ImageStream X flow cytometer

Department of Health and Human Services, National Institutes of Health | Published November 7, 2014  -  Deadline November 21, 2014
cpvs

COMBINED SYNOPSIS / SOLICITATION This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is HHS-NIH-NIDA-(SSSA)-15-021 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5-Test Program for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-76 effective August 25, 2014. This acquisition is unrestricted. The associated NAICS code 811219 and the small business size standard $20.5. STATEMENT OF OBJECTIVES The purpose of this acquisition is for the renewal of the Maintenance Agreement of ImageStreamX imaging flow cytometer that serves a common Flow Cytometry Core Facility used by NINDS and other NIH institutes. Title: Service Contract for Amnis ImageStream X flow cytometer CONTRACTOR REQUIREMENTS (SCOPE OF WORK) Scope of Work The National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH) mission is to seek fundamental knowledge about the brain and nervous systems and to use that knowledge to reduce the burden of neurological disease. The NINDS Flow Cytometery Core Facility has a need to provide routine use of ImageStreamX imaging flow cytometry to support over 120 basic and clinical research projects in 45 NINDS and other intramural programs. ImageStreamX flow cytometry instrument is a highly complex system combining high-throughput microscopic imaging of cells through a flow cell that requires maintenance and repair only by qualified personnel. The system is currently covered under the existing service maintenance contract, which expires on December 10, 2014. Project requirements: Contractor will provide all labor and replacement parts to maintain normal operation of existing ImageStreamX flow cytometer (Serial# ISX106) located at the National Institutes of Health, 49 Convent Drive, Building 49, Room 2B-63, Bethesda, MD, 20892. Specific items supported are as follows: Item # Description 600101 ImageStream X sn: ISX 106 602100 Data Analysis Workstation 602120 405 nm Laser 602130 658 nm Laser 602170 Full Bright Field 602180 12 Imaging Channels The term of coverage will be December 11, 2014 through December 10, 2015 with 4 option years. Service will be provided Monday through Friday, excluding Federal holidays. The contractor shall provide: 1. The contractor shall perform two Preventive Maintenance Inspections during the twelve month period. The first will be performed during March, 2015 and the second will be performed during September, 2015. Preventive Maintenance will be performed by an Amnis/EMD Millipore certified service technician. Service will include installation of hardware upgrades, calibration of the flow cytometer, optimization of alignment for critical components, replacement of wear items, and overall inspection of the instrument to confirm that it is operating at peak efficiency and reliability. 2. The contractor shall provide phone support from a certified technician within 1 business day and on-site service within 3 business days after it is determined that the problem cannot be resolved through phone support. 3. Emergency Service: Time to arrive on site remains the same as for Service. Time to complete service: Discussion regarding required labor, parts and cost will be the basis for mutual agreement of the parties to set a firm completion date if the timeframe exceeds 4 weeks. 4. Replacement parts: Contractor shall furnish all required Amnis/EMD Millipore certified replacement parts at no additional cost to the Government. 5. Software Updates/Service: Contractor will provide free of charge any revisions to Amnis/EMD Millipore IDEAS and INSPIRE image analysis and acquisition software during the Agreement term. 6. Service Exclusions: Contractor will not be responsible for repairs necessitated by user misuse or error, repairs required due to operator negligence, replacement of accessories and consumables, or problems associated with environmental conditions. 7. Personnel Qualifications: Service personnel need to have the experience deemed appropriate by Amnis/EMD Millipore as evidenced by completing the requisite training mandated by the manufacturer and being certified by the manufacturer. All Field Service Engineers shall have completed the required training and be certified by the manufacturer. Contractor shall produce copies of these certificates for the field personnel that service the National Institutes of Health for verification of eligibility to perform this service. Place of Performance: Initial assessment of repair needs and any service that can be performed in house will be done on-site at the NIH campus. PERIOD OF PERFORMANCE Coverage will be from December 11, 2014 through December 10, 2015 Option Year 1: December 11, 2015 through December 10, 2016 Option Year 2: December 11, 2016 through December 10, 2017 Option Year 3: December 11, 2017 through December 10, 2018 Option Year 4: December 11, 2018 through December 10, 2019 Type of Contract Contemplated Fixed Price Purchase Order GOVERNMENT RESPONSIBILITIES Government will provide Contractor personnel reasonable access to the Equipment whenever Service is required. Government will cooperate with Contractor personnel so that Service can be performed efficiently and without interruption. Contractor shall be allowed use of Government equipment which Contractor personnel deem necessary to perform the Services. Selection Criteria The Contractor shall be evaluated on their proposal as follows: - All Field Service Engineers shall have completed the required training and be certified by the manufacturer. Contractor shall produce copies of these certificates for the field personnel that service the National Institutes of Health for verification of eligibility to perform this service. - Provide a minimum of four (4) past performance references for maintenance service on like equipment (name of company, name of end user, end user phone number) - Evidence that all required parts utilized for maintenance and repair are certified manufacturer parts - Demonstrate the ability to respond to repair and maintenance issues within two business days - Lowest Price Technically acceptable. Acceptance FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications - Commercial Items, with its offer. FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. FAR clause 52.212.-2, Evaluation - Commercial Items, is applicable to this requirement. Offers will be evaluated on (1) the capability of the service quoted and whether it meets the essential requirements as specified in the scope of work; and (2) price. FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by November 21, 2014, 8:00 am EST and must reference number HHS-NIH-NIDA-(SSSA)-14-750. Responses may be submitted electronically to andriani.buck@nih.gov or by U.S. mail to the National Institute of Drug Abuse (NIDA), Station Support / Simplified Acquisition Branch (SS/SA), 31 Center Drive, Building 31, Room 1B59, Bethesda, Maryland 20892-2080, Attention: Andriani Buck. Fax responses will be accepted at (301) 480-1358. Contact Andriani Buck at 301-402-1677 for information regarding the solicitation.

Purchase of cGMP Human Growth Hormone Releasing Factor (I-44)

Department of Health and Human Services, National Institutes of Health | Published November 10, 2014  -  Deadline November 21, 2014
cpvs

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, "Streamlined Procedures for Evaluation and Solicitation for Commercial Items," as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested, and a written solicitation document will not be issued. This solicitation is a "Request for Quotation" and being competed under FAR Part 6.1, Full and Open Competition. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2005-77, effective October 14, 2014. The associated North American Industrial Classification System (NAICS) code for this procurement is 325411 with a small business size standard of 750 of employees. In accordance with FAR Sub-Part 52.211-6, this is a "BRAND NAME OR EQUAL" requirement. The National Institute of Health, Office of Purchasing and Contracts, is seeking to purchase Brand Name or Equal Human Growth Hormone Releasing Factor (GRF), (1-44) as described in the Statement of Work. All interested and qualified businesses are encouraged to provide a quotation/offer. STATEMENT OF WORK The National Institutes of Health (NIH) Clinical Center (CC) is a clinical research hospital providing all medical services for patients participating in human research protocols of the NIH. The CC provides patient facilities and services for clinical investigations by the NIH Institutes, research in related areas and supervises residency and other training programs. The NIH Clinical Center Pharmacy Department provides pharmaceutical care and dispenses medications to inpatient and outpatients enrolled on clinical investigational studies. Clinical Center pharmacists provide research support to health care providers and investigators. Pharmacy staff members conduct and participate in research programs that enhance knowledge regarding optimal dosing and appropriate use of investigational and commercially available agents. The Pharmacy Department's Pharmaceutical Development Section manages investigational drug inventories through a computerized information system, prepares customized investigational drug products, and assists investigators in filing Investigational New Drug (IND) applications with the FDA. Current Good Manufacturing Practice (cGMP) Section 501 [21 U.S.C. § 351] (a) (2) (B) of the Federal Food, Drug, and Cosmetic Act requires the methods, facilities, and controls used for the manufacturing, processing, packaging, and holding of drug products to conform to current Good Manufacturing Practices (cGMPs) in order to ensure the safety, identity, strength, quality, and purity of the drugs produced. The federal Food and Drug Administration (FDA) has general rulemaking authority to issue regulations for the efficient enforcement of the act. The FDA regulates pharmaceutical manufacturing through the Code of Federal Regulations (CFR), specifically the following sections: 21 CFR Part 210 Current Good Manufacturing Practice in Manufacturing, Processing, Packing, Or Holding Of Drugs; General Part 21 CFR Part 211 Current Good Manufacturing Practice for Finished Pharmaceuticals 21 CFR Part 600 Biological Products: General Part The FDA further discusses procedures and practices to meet cGMPs through various venues, including the publication of Guidance for Industry documents, several of which are applicable to the operations that take place in PDS. Two very relevant and important guidance documents include cGMP for Phase I Investigational Drugs and Sterile Drug Products Produced by Aseptic Processing - cGMPs. The requirement for maintenance and cleaning of pharmaceutical process systems and equipment are clear (21 CFR 211.67 Subpart D and FDA guidance and inspection documents) and linked to the regulations through these documents and venues. Regulatory Requirements for PDS Operations PDS engages in the manufacture, packaging, distribution, and holding of drugs and drug products for Phase I and Phase II clinical trials, and contributes to the submission of IND applications to the FDA. The FDA makes clear that an investigational drug for use in a Phase 1 study is subject to the statutory requirements set forth at 21 U.S.C. 351(a)(2)(B). Drugs for Phase 2 or Phase 3 study must comply with all regulations set forth by 21 CFR 210-211. As such, PDS is subject to the regulatory authority of the FDA and must operate under cGMP conditions. Additionally, vendors providing equipment or services to PDS must know, understand, and apply cGMP conditions since PDS is reliant upon the manufacturer or service provider to meet many of the required quality aspects of the goods or services provided. PURPOSE In many cases the Pharmacy is required to find a suitable source for raw materials needed to produce the drug dosage forms needed to complete the goals of approved clinical trials. The Pharmacy has made many hundreds of purchases over the years and the practices employed are, in most cases reviewed by the FDA. In effect, on hundreds of occasions, the FDA has agreed that Pharmacy has made a proper choice in this regard. The judgement, based on experience, of members of the Pharmacy who make these selections is a primary factor in the decision process. Other factors to be considered in these selections are compendial specifications and designation (inclusion in the United States Pharmacopeia or National Formulary, U.S.P./N.F. or in foreign equivalents), the issue of whether the chemical was made under current Good Manufacturing Practices (cGMP) as defined by the United States Food and Drug Administration (U.S. FDA) or, in some cases, the recognized available grade of the material, e.g. - food grade or analytical grade for example. SCOPE OF WORK • The GRF 1-44 needed must be at least 98% peptide pure. • It must be a white powder. • It must attain a solubility in water of at least 1 mg/mL. • It must have a specific rotation value at C=0.1 in water at 20 degrees C in 1% • Acetic acid of approximately -78.99 degrees. • The molecular weight must be 5040.4 • The peptide must be certified as being prepared under cGMP conditions and be labeled as such. • A reference standard must be available from the source so that analytical comparison can be made. • A certificate of analysis showing the specifications for acceptance of the provided material and the actual values found in testing must be provided. FOR ALL TERMS, CONDITIONS, AND QUOTATION INSTRUCTIONS, PLEASE SEE THE ATTACHED DOCUMENT: "Growth Hormone Releasing Factor (GRF), (I-44) Synopsis/Solicitation."

Sign Language Interpreting and Computer Aided Real Time Transcribing Services

Department of Health and Human Services, National Institutes of Health | Published November 14, 2014  -  Deadline December 1, 2014
cpvs

November 14, 2014 Pre Solicitation Notice # HHS-NIH-OD-OLAO-SS-14-010 Sign Language Interpreting and Computer Aided Real Time Transcribing Services THIS IS A NOTICE OF INTENT, NOT A SOLICITATION FOR COMPETITIVE PROPOSALS. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. The National Institutes of Health's Office of the Director, Office of Logistics and Acquisitions Operations, on behalf of the Office of the Director (OD), Office of Research Services (ORS), Division of Amenities and Transportation Services (DATS), intends to negotiate a fixed price type contract on a sole source basis with Access Interpreting under NAICS code 541930 for one year until the five year contract is solicited for 2016. This procurement will be done pursuant to 41 U.S.C. 3304 (a) (1) and FAR) 6.302- (1). Access Interpreting is the only organization which can effectively fulfill the interpreting service requirement at the level that is immediately needed. In recent years, the level of service the NIH requires in their interpreting services and CART contractor increased due to the continual growth, daily work routine of the D/HH employees, NIH guests and patients. A service provider with the appropriate expertise, infrastructure and operational capabilities to efficiently provide all the services described in the Statement of Work is required. In addition to the above requirements, there are also a number of "open to the public" events regularly scheduled that a new contractor might not be able to fulfill immediately. It would be risky the hearing impaired community to not have the ability to work or participate in these activities. This could adversely affect productivity and place the NIH in jeopardy of not being in compliance with the NIH Manual Issuance - "2204 Reasonable Accommodations." Capability Statement Requirements and Delivery Instructions. This notice is not a solicitation for competitive proposals. However, if any other interested party believes that they can meet the requirements, they may submit a statement of capabilities. The capability statement and any other information furnished must be in writing and must contain material in sufficient detail to allow the government to determine if the party can meet the requirements as described in the statement of work. Submissions will be evaluated based on (a) Staff expertise, (b) Technical approach to perform the work described in the statement of work (c) prior completed projects of similar nature; (d) corporate experience and management capability. Submission of Capability Statements: Capability statements and related materials received by the Contract Specialist no later than December 1, 2014 @ 10:00AM Eastern Time will be considered by the government. Written responses received after December 1, 2014 @ 10:00 AM Eastern Time will not be accepted. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. (a) Responses can be emailed to gerstels@mail.nih.gov. When mailing your capabilities through the U.S. Postal Service use the following address: National Institutes of Health, Office of Logistics and Acquisition Operations, (OLAO), 6011 Executive Blvd., Room 629C, Bethesda, MD 20892. ATTN: Sharmaine Fagan-Kerr (formerly Gerstel). (b) When hand delivering, or using a courier service such as: UPS, Federal Express, etc., use the following City, State, and Zip Code: Rockville, MD 20852. Responses by Facsimile (FAX) will not be accepted. Disclaimer and Important Notes. This is not a solicitation for competitive proposals. It is emphasized that responses to this Pre Solicitation Notice are not considered offers and cannot be accepted by the Government to form a binding contract. Confidentiality - No proprietary, classified, confidential, or sensitive information should be included in your response. Point of Contact: Sharmaine Fagan-Kerr, Contract Specialist, Phone: (301) 594-3744 Please address questions via e-mail to Sharmaine Fagan-Kerr (formerly Gerstel) at gerstels@mail.nih.gov Statement of Work (SOW) National Institutes of Health (NIH), Department of Health and Human Services (HHS) 1. Title: NIH Sign Language Interpreting Services and Computer Aided Real Time Transcribing Services Performance Based Contract. 2. Background: As the world's premier biomedical research institution, the NIH is committed to meeting the needs of staff, patients, guests and visitors who are Deaf/Hard of Hearing (D/HH). The NIH uses interpreting services and Computer Aided Real Time Transcribing Services (CART) to facilitate communication for events/meetings such as work-related meetings, training sessions, safety talks, discussions on work related procedures, policies and assignments, human resources actions, conferences and any events attended by (D/HH) persons, as well patient visits and appointments. In 2008, NIH used over 21,000 hours of interpreting and CART services. Over the last five years, NIH has used an average of over 19,000 hours annually. Historically, interpreting services have increased 5 to 7 percent a year. The services are primarily performed at on- and off-campus locations. In addition to the main NIH Bethesda Campus, services may be required to be performed at other NIH locations throughout the United States. The contractor is to provide qualified interpreters and CART services to meet these requirements. The need for a qualified interpreting services and CART contractor exists because of the continual growth, professional development, and daily work routine of the D/HH employees, NIH guests and patients. There are also a number of "open to the public" events regularly scheduled. The NIH currently provides interpreting and CART services through a centrally-funded and managed performance based contract. The NIH has established under the Office of the Director (OD), Office of Research Services (ORS), Division of Amenities and Transportation Services (DATS) a Program Management Team to oversee these requirements and services provided to our customers through this contract. This team consists of the Program Manager, a Federal Government employee in the DATS who is responsible for oversight and management of the contract. In addition, DATS has one full-time and one part-time Quality Assurance Specialist to assist in handling the day to day operations and surveillance of the contract as well as resolve any issues that may arise. 3. Project Objectives: The DATS Program Management Team will maintain primary responsibility and oversight of the contract. This SOW is for functional and technical assistance in this effort. This one year Performance Based Service Contract with four (4) option years will be to provide interpreting and CART services to the NIH. NIH is requesting qualified offeror's to respond to the tasks described in this SOW. 4. Scope: The NIH employs approximately 30,000 persons of which an estimated 100 are self-identified as D/HH employees, but also numerous events that are open to the public, scientific and research symposiums, patients, patient visitors, contractors, etc. who are located primarily on the NIH Bethesda Campus but at our leased facilities throughout Montgomery County, MD as well. There is an expectation that this number of D/HH employees will grow by 1 to 2 % each year. NIH employees are also located in Frederick, Baltimore, North Carolina, and Montana and in other parts of the United States where there is/may be a need to provide interpreting and CART services to employees and guests. On an individual or case by case basis, the NIH will make prior arrangements with the contractor to reimburse for certain out-of-pocket expenses incurred by the interpreter (i.e., mileage, parking, tolls, lodging) in accordance with U.S. Government/NIH travel regulations if the interpreting or CART request is not in an NIH recognized duty station. Interpreting services are used principally for meetings, which can include supervisory-employee meetings, training classes, etc. Interpreting and CART services are also needed for patient consultations, lectures and special events, which include, but are not limited to, a large gathering of persons which may include D/HH persons (i.e., symposiums, conferences, lectures etc.) In addition, any activities sponsored by NIH involving government employees, patients, guests, and visitors in accordance with the guidance found in the NIH Manual Issuance - 2204 Reasonable Accommodations http://www1.od.nih.gov/oma/manualchapters/management/2204/2204.pdf Section J: Sign Language Interpreting Services may also require interpreting and CART services. Types of Interpreting Services Required Basic interpreting services include but are not limited to, ASL, sign language, oral, tactile, close-vision, deaf interpreting, cued speech, Video Relayed Services, Video Remote Interpreting or combination of services. Scientific interpreting services include the basic interpreting services above, but also require the interpreter to have a working knowledge of the vocabulary that is specialized and/or technical in the area of scientific and medical applications. All interpreters assigned to provide services under this Performance Based Service Contract should be or quickly become familiar with government vernacular. The contractor must be able to staff at all times between 27 - 44 interpreters which will be evaluated as follows: • Minimum of 12-15 qualified interpreters with documented experience in scientific interpreting; • Minimum of 4 Certified Deaf Interpreters; • Minimum of 15-20 qualified interpreters to handle all non-technical routine interpreting services; • Minimum of 5 CART reporters able to serve NIH. The above minimum staffing numbers can/may increase/decrease based on business needs of the NIH. All of the above minimum staffing numbers are considered Key Personnel for this SOW. 5. Functional Specific Tasks: a. Interpreters assigned to perform services outlined in this SOW should have a college degree (A.A., B.S., B.A., M.A., or M.S.), in an interpreting related field, with at least three years of current interpreting work experience. If the interpreter has no college degree, he/she must have at least five (5) years of current interpreting work experience preferably for Federal Agencies, Private Industry similar to the size and scope of the NIH, or Medical/Research Facilities. Interpreters must also be certified through screening as recognized by the National Registry of Interpreters for the Deaf (RID) and the National Association for the Deaf (NAD) levels 4 or 5 only. b. Fluency of sign language on the entire sign language continuum to effectively facilitate communication between D/HH employees and hearing employees; c. Ability to perform at least one of the following: (1) interpret voice to sign, (2) interpret sign to voice, (3) oral transliteration, (4) tactile, (5) close-vision, and (6) cued speech; Must have documented certifications for various disciplines as specified by RID and NAD levels 4 and 5. Please refer to attached website http://www.rid.org/education/edu_certification/index.cfm d. Ability to accurately interpret in a variety of settings, including those that require specialized, technical, legal, scientific, medical, library, and information technology vocabulary, and familiarity with government vernaculars; e. Ability to keep pace with communications in conferences, meetings, seminars, training classes, etc.; f. Ability to negotiate with speakers as ‘colleagues' to mediate pace of communication as necessary and appropriate; or voice interpret when a D/HH person=s speech is not easily understood; g. Ability to abstract, select and highlight within context when dealing with complicated concepts, idioms, etc.; h. Practicing knowledge of and adherence to the tenets of the RID and NAD Code of Professional Conduct which include: 1. Interpreters adhere to standards of confidential communication; 2. Interpreters possess the professional skills and knowledge required for the specific interpreting situation; 3. Interpreters conduct themselves in a manner appropriate to the specific interpreting situation; 4. Interpreters demonstrate respect for consumers; 5. Interpreters demonstrate respect for colleagues, interns, and students of the profession; 6. Interpreters maintain ethical business practices; and 7. Interpreters engage in professional development. The complete version of the RID and NAD Code of Professional Conduct may be found at the following web address: http://www.rid.org/UserFiles/File/NAD_RID_ETHICS.pdf i. Knowledge of the diverse cultures within NIH D/HH community to effectively work as an interpreter; j. Knowledge of the diversity of culture and skill to prepare for each interpreting assignment including the knowledge needed to assist in setting up an environment that is conducive to meeting the communication needs of both the hearing and deaf consumer; k. Ability to effectively assess the language needs of the deaf consumer; l. Ability to apply the analytical skills necessary to determine which communication modes the Deaf consumer is utilizing. m. In certain circumstances color appropriate attire may be necessary. This is the responsibility of the contractor. n. The Government shall not exercise any direct supervision or control over the Contractor employees performing these services under this contract. Such Contractor personnel shall be accountable to the Contractor, who, in turn, shall be accountable to the Government; and o. The Contractor should use and evaluate all latest technology available when providing interpreting services for NIH. This should and may include the use of Video Relay Services and/or Video Remote Interpreting where applicable. The Government Reserves the right to modify and to make use of improved technology to enhance the provision of these services. Qualified CART reporters must meet the following minimum knowledge, skills, and abilities: a. Demonstrate Knowledge, skills and abilities in the Core Competency areas defined by the National Court Reporters Foundation. In addition reporters must be a Certified CART Provider (CCP); b. Ability to provide small venue CART services to be used by D/HH staff, patients and visitors; c. CART reporter must be able to handle and report various medical, scientific and technical terms proficiently; d. CART translation shall be provided in real time; and e. One unedited transcript of the service shall be provided to the consumer upon their request. 6. Deliverables The contractor shall provide adequate interpreting and CART services as well as the overall management of the provisions of these services in order to meet our growing demand. To the extent that the DATS Program Office can, the NIH plans to advise the contractor of an interpreting service requirement at least five business days in advance of the event/meeting. The requests will include a description of the event/meeting, location, planned duration, type of service requested (Basic, Medical, Scientific, Emergency, Etc.), and recommended interpreter (if requested). All requests received five business days prior to an event/meeting must be filled and confirmed within one business day of receipt of request. Any requests received with less than five working days advanced notice should be filled according to the Performance Requirements Summary (pages 9-10). Deliverables and Reporting Requirements are such that the Contractor shall provide a database similar to the current NIH Interpreting Services Database that will have the capability to compile and review the following reports and statistical data: reporting capability should be prepared to report on services being provided on a daily, weekly, monthly, yearly for regular types of reports, and on an ad-hoc basis depending on necessity by the Government: a) Confirmation of Requests b) Update of Individual Requests c) Manage Status of Requests d) Interpreting Services Reports e) Monthly Invoices f) Data by Institutes g) Consumer Evaluation of Requests Other standard data to be included on any data base must include: Name/NIH Identification Card Number, One-Time or On-Going Request, Date, Location, Type of Event (i.e. Conference, Interview, Meeting, Training, On-call, Medical, Patient, Scientific, etc.), Open/Closed to the Public, Type of Service Requested (i.e. ASL, Oral, Tactile, Close Vision, Cued Speech, CART, etc.), Special Instructions, and Date Requested/Date Cancelled. This standard reporting can be modified as necessary to ensure that appropriate data is being collected. Note: This is subject to further enhancement throughout the term of the contract through active discussion with the Contractor, Contracting Officer, Project Officer, and Customers. The Government retains the right to modify this deliverable as required. All reports are the sole property of the Government, and can only be released to the Contracting Officer or Project Officer. 7. Contract Requirements 1. The NIH requires that each interpreter on the vendor's submitted list be approved by the NIH. These interpreters cannot be replaced or substituted without prior written approval from the Project Officer, except on an emergency basis; 2. Each Interpreter and CART reporter shall be able to obtain and display an NIH ID and also display at all times the company of employment's ID. The contractor shall make profiles of its interpreters available on its website. These profiles should include a brief bio, including qualifications and a picture of the interpreters; 3. The NIH has a small need for interpreting emergency and non-emergency requests during both NIH business hours and non-business hours which may also occur during Federal government holidays or weekends and the contractor will be required to fulfill these infrequent requests; 4. The NIH will develop and distribute an evaluation survey which customers can complete and return to the project office. This may be in one of several ways including hard copy or electronic format. It should be noted that customers can also submit their own satisfaction or dissatisfaction comments to the Program Office; 5. The assigned interpreter shall make personal contact with the organizer/requestor of any assignment as appropriate. The NIH understands that emergency or last minute/late requests may not allow for this interaction between the contractor and the customer; 6. Operation during inclement weather and Government Closure may be required. It is the contractor's responsibility to insure sufficient staff is available to support any non-cancelled operations during inclement weather, even if the Government has announced Official Closure or Liberal Leave. This also applies to events as stated in Number 3 above. If contact cannot be made with the Event Requestor as stated in Number 5 above, the Contractor must contact the Project Officer PRIOR to the event to determine if there is a need to provide service. 7. The contractor shall develop and maintain a reservation system matching employees to preferred interpreters. This would include a first and second preference interpreter for a specific employee. If those interpreters are not available for the D/HH employee, the contractor may then assign another interpreter to the assignment. 8. Technical Requirements: The NIH requires coordination of all aspects of the interpreting services scheduling. The Contractor shall provide the type of interpreting services reservation system approved with the award of the contract. The reservation system shall provide the data necessary to confirm and schedule requests, track the contract, and track the event/meeting data (i.e. date, time, place, length of event/meeting, type of event/meeting, requestor, and interpreter(s) assigned), and invoice the NIH for services rendered 508 Compliance: Section 508 of the Rehabilitation Act requires that Federal agencies' electronic and information technology is accessible to people with disabilities. This courseware product must be Section 508 conformant. Specifically, the end product must be conformant with all applicable provisions, including: • 1194.21 Software Applications and Operating Systems • 1194.22 Web-based Intranet and Internet Information and Applications • 1194.24 Video and Multimedia Products • 1194.31 Functional performance criteria • 1194.41 Information, documentation, and support These provisions can be found at http://www.access-board.gov/sec508/standards.htm Information Security Training HHS policy requires contractors/subcontractors receive security training commensurate with their responsibilities for performing work under the terms and conditions of their contractual agreements. The contractor shall ensure that each contractor/subcontractor employee has completed the NIH Computer Security Awareness Training course at: http://irtsectraining.nih.gov/ prior to performing any task order work, and thereafter completing the NIH-specified fiscal year refresher course during the period of performance of the task order. Offeror's Official Responsible for Information Security The offeror shall include in the "Information Security" part of its Technical Proposal the name and title of its official who will be responsible for all information security requirements should the offeror be selected for an award. Information Technology Rules of Behavior The contractor/subcontractor employees shall comply with the NIH Information Technology General Rules of Behavior at: http://irm.cit.nih.gov/security/nihitrob.html. Personnel Security Responsibilities The contractor shall perform and document the actions identified in the "Employee Separation Checklist" (http://nitaac.nih.gov/downloads/ciosp2/Employee_Separation_Checklist.doc) when a contractor/subcontractor employee terminates work under this contract. All documentation shall be made available to the Project Officer and/or Contracting Officer upon request. 9. Government Furnished Property NIH shall provide for use by contractor one office for on-call interpreters as well as two computers for use by on-call interpreters. 10. Quality Standards and Records & Reports: The contractor shall comply with their proposed quality assurance plan. The NIH is committed to providing quality interpreting services for its requesters and users; to creating an effective service relationship between the NIH, Contractor, and our many diverse customers. We are committed to maintaining the highest standards for providing interpreting services as a government agency. The Contractor shall maintain records and prepare reports as set forth in this SOW. A copy of all reports shall be maintained and be available for inspection by the Government at all times. From time to time, the Contractor and their employees may be required to make written and/or oral statements to authorized Government agencies due to a particular incident or issue. Any written statements provided shall be considered a report under the terms of this contract. All records and copies of reports shall be turned over to the Project Officer within five (5) calendar days after completion. The Government reserves the right to modify any performance standards and/or metrics during the life of this contract, in order to ensure that the appropriate outcomes are being assessed and that the performance standards are appropriate. Changes will be accomplished via a bi-lateral contract modification The Contracting Officer is the only person with the authority to act as an agent of the Government under this contract. Only the Contracting Officer has authority to perform any of the following: • direct or negotiate any changes in the Solicitation or specifications • modify or extend the period of performance • change the delivery schedule • change any terms and conditions of the contract. . Under the terms of this SOW, contractors are continuously encouraged to use innovative approaches in addressing the requirements contained in this solicitation. That creativity flexibility will be evaluated in terms of the extent to which it successfully addresses the requirements and constraints of the SOW and the likely effectiveness of the proposed performance standards, monitoring approaches, and incentives in producing optimal contract results while lessening the Government's oversight burden. This partnership may come from many resources that are available - the Contractor, the assigned interpreters, the NIH, and most importantly, our customers who use these vital services. The Contractor shall continually monitor the quality of interpreting services which will include internal methods for monitoring, identifying problems and deficiencies and effectively alleviating them to produce a quality level of services to the NIH. The Contractor shall propose to meet these stated quality standards and shall state how it will achieve and monitor them including any additional proposed quality standards. 1. At least 98% of all requests received at least 5 business days in advance will be filled. 2. At least 90% of all requests received less than 5 business days in advance are filled. 3. At least 85% of all requests received for that particular day (day of) will be filled. 4. At least 90% of requests received outside normal business hours will have an interpreter respond onsite within 40 minutes. 5. At least 98% of all requests will be initially confirmed and scheduled by the vendor with accurate information based upon user provided information on each request (i.e., date, times, type of services, any special instructions, etc.). 6. At least 98% of all requests received are confirmed by the vendor within one (1) business day (e.g., all requests received during the hours of 7:00 a.m. to 6:00 pm must be confirmed to the Project Office no later than 4:00 p.m. the following business day. For requests received on a Friday between those hours, the vendor will provide the confirmation on Monday). 7. At least 95% of all confirmed interpreters respond to the properly scheduled event at least 15 minutes prior to start of the event. The following represents the acceptable percentage that respondents will rate the contractor. Excellent 30% minimum Very Good 45% minimum Average 22% minimum Below Average 2% maximum Poor 1% maximum The NIH understands that this is a demanding and growing industry. During the Project Office's monthly reconciliation process, it will identify performance standards that have been exceeded for that period. While we cannot place a cap or threshold on the number of requests requiring services over a given period, the NIH will provide incentives for each performance standard exceeded as shown on the Performance Requirements Summary. (Pages 9 - 11) 11. Standards of Conduct - Personnel: Interpreting services are vital to the success of many of the NIH events or programs, regardless of whether they are open or closed to the public. Our employees, guests and visitors will receive quality services by professional interpreters. The following standards of conduct are specific to this contract, as well as adherence to the NIH Rules of Conduct. These standards have been developed to ensure that Interpreting or CART services are provided in the most effective and professional manner: • The contractor shall provide the most accurate translation, interpretation or CART services possible; • The contractor shall receive assignments directly from the Government and shall not act on requests received directly from customers; • The contractor shall not perform any services for individuals, meetings, events on a volunteer basis; • The contractor shall abide by all confidentiality rules and standards and shall maintain professional integrity during and after all assignments. The contractor shall not discuss the content of any service(s) performed under this contract with any persons other than the Project Officer/Contracting Officer • The contractor shall not offer personal opinions, advice, or counsel before, during or after an assignment; • The contractor shall direct all questions or problems relating to work performed under this contract to the Project Officer/Contracting Officer for consideration; • The Interpreter/translator shall uphold all policies of the Government not specifically listed in or as periodically updated during the duration of this contract; • Other Federal Personnel Rules of Conduct and Behavior that are not specifically cited or that may be implemented during the life of this contract; and • The contractor shall not represent himself/herself or permit himself/herself to be represented to the public as an agent of the Government, nor shall he in anyway use this association with the Government in any type of advertising. 12. Post - Award Administration: Contractor performance will be monitored in accordance with the Quality Assurance Performance Requirements and by review of monthly status and invoice reports. Monthly reports will be provided to the project management team and will include the following monthly information: the number of hours of interpreting and CART services provided per month, and billable cancellations per month. In addition the Project Officer in accordance with the Quality Assurance Plan will calculate incentives/disincentives based on contractors performance. Project Officer will approve and request invoicing for services no later than the 15th of each month. Accurate/ Confirmed Requests 98% of all interpreting services requests received more than 5 days in advance of date are filled. Project Officer will review and compare vendor=s and government=s monthly records to determine if vendor is meeting the stated standard. Last Minute Requests 90% of all interpreting services requests received less than 5 days in advance of the requested date are filled. Project Officer will review and compare vendor=s and government=s monthly records to determine if vendor is meeting the stated standard. Day-of Requests 85% all interpreting services requests received during normal working hours of that day are filled. Project Officer will review and compare vendor=s and government=s monthly records to determine if vendor is meeting the stated standard. Emergency Off-hour Requests 90% of all interpreting services requests received after normal working hours will have an interpreter respond on-site within 40 minutes. Project Officer will review and compare vendor=s and government=s monthly records to determine if vendor is meeting the stated standard. Scheduling and Confirmation Accuracy All interpreting services requests will be scheduled/confirmed with accurate information (date, times, type of service and/or special instructions). Project Officer will review and compare vendor=s and government=s monthly records to determine if vendor is meeting the stated standard. Confirmation of Request Delivery All interpreting services requests are confirmed by the vendor within 1 (one) business day of request receipt. Project Officer will review and compare vendor=s and government=s monthly records to determine if vendor is meeting the stated standard. Confirmed Interpreter Response Time All interpreters respond to the scheduled requested event at least 15 minutes prior to the start of the event. The Point of Contact (derived from the request) must be appraised of the interpreters' arrival and departure for each event. Project Officer will review customer=s evaluation sheets and other consumer feedback to determine if the interpreter arrived 15 minutes prior to the start of the event and made appropriate contacts.

Preventive Maintenance for FACSAria Fusion 4 Laser System

Department of Health and Human Services, National Institutes of Health | Published November 14, 2014  -  Deadline November 21, 2014
cpvs

The National Institutes of Health, Office of Logistics and Acquisition Operations, OLAO intends to award a firm fixed price purchase order on a sole source basis with Becton, Dickinson and Company, 2350 Qume Drive, San Jose, CA 95131, on behalf of the National Eye Institute under the authority of FAR 13.106-1(b)(1) and FAR 6.302-1(a)(2)(iii). The proposed acquisition is for maintenance services to provide all labor, material and equipment to provide preventive maintenance for government-owned equipment on the following : FACSAria Fusion 4 Laser System for the period December 6, 2014 to December 5, 2015. This notice of intent is not a request for competitive quotations; however, any quotation received within seven (7) calendar days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Interested parties may submit their company’s detailed capabilities statement, and references. Interested parties shall include, in writing, the company name, address, point of contact, telephone number, and business size; a statement regarding their capabilities and qualifications; and any additional supporting literature. If no affirmative responses are received within seven (7) calendar days of this notice to determine whether a qualified source is more advantageous to the Government, the order will be issued to Becton, Dickinson and Company. The North American Industry Classification System (NAICS) for this requirement is 334516. Responses to this notice must be received no later than 12:00 PM Eastern Standard Time, November 21, 2014. This notice of intent is not a request for competitive proposals, quotes or a solicitation of offers. The point of contact for this action is Ms. Van Holley, Contract Specialist, 6011 Executive Blvd., Room 537-B, Rockville, MD 20852, email: holleyv@od.nih.gov . The National Institutes of Health, Office of Logistics and Acquisition Operations, OLAO requires that all contractors doing business with OLAO must be registered with the Central Contractor Registry (CCR). No award can be made unless the vendor is registered in CCR. For additional information and to register in CCR please access the following website: http://www.sam.gov/. In order to register with the CCR and to be eligible to receive an award from this acquisition office, all offerors must have a Dun & Bradstreet Number. A Dun & Bradstreet number may be acquired free of charge by contacting Dun & Bradstreet on-line at https://www.dnb.com/product/eupdate/requestOptions.html. The government now encourages all contractors to submit their Certification and Representation (ORCA) thru the on-line System for Award Management (SAM). The SAM is the single source for vendor data for the federal government. Contractors should go on-line at www.sam.gov. Award will not be made to any contractor that is not registered in CCR and SAM. Responses should be sent to Ms. Van Holley, Contract Specialist, 6011 Executive Blvd., Room 537-B, Rockville, MD 20852. This procurement is to be processed using Simplified Acquisition Procedures (FAR Part 13) in conjunction with FAR Part 12 Commercial Item Acquisition of Commercial Items. There is no solicitation package available.

Lab Management Support Services

Department of Health and Human Services, National Institutes of Health | Published November 14, 2014  -  Deadline November 20, 2014
cpvs

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). THIS IS A NOTICE OF INTENT, NOT A REQUEST FOR A PROPOSAL. A SOLICITATION DOCUMENT WILL NOT BE ISSUED AND PROPOSALS WILL NOT BE REQUESTED. This is a Follow-On Requirement. ISSO AND 508 COMPLIANCE NOT REQUIRED. INTRODUCTION: The National Institute of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Office of Acquisition (OA) on behalf of the National Human Genome Research Institute, (NHGRI), intends to negotiate and award a purchase order on a non-competitive sole source basis to BTR Inc., 731-E Walker Road, Great Falls, Virginia 22066 to continue providing: laboratory management support services to the National Institutes of Health, National Human Genome Research Institute, including administrative, regulatory, equipment maintenance and repair, and waste recycling and management A. Background: The National Institutes of Health (NIH) mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability. The National Human Genome Research Institute (NHGRI) mission has expanded to encompass a broad range of studies aimed at understanding the structure and function of the human genome and its role in health and disease. To that end NHGRI supports the development of resources and technology that will accelerate genome research and its application to human health. A critical part of the NHGRI mission continues to be the study of the ethical, legal and social implications (ELSI) of genome research. The National Human Genome Research Institute (NHGRI), Division of Intramural Research (DIR) was established to serve as a hub where development of technology for the rapid isolation and analysis of disease genes will be carried out. The DIR's basic research laboratories and clinical branches develop and use the most advanced techniques to conduct research in medical genetics. Research includes identifying and understanding the molecular basis of human genetic disease and planning and carrying out clinical trials to test methods for the treatment. B. Purpose and Objectives: The purpose of this contract is to provide laboratory management support for NHGRI, including administrative, regulatory, equipment maintenance and repair, and waste recycling and management. The National Human Genome Research Institute (NHGRI) has a recurring need for Genetic Disease Research Branch; Medical Genomics and Metabolic Genetics Branch to manage their laboratories, including administrative, regulatory, equipment maintenance and repair, and waste recycling and disposal. The scientific research includes programs T cell signaling, Limb development, inherited human disorders, common variants and human disease and genetic components of coat color. In order to continue supporting this vital ongoing research, the branch needs lab management support staff. C. Scope of Work: The contractor shall have experience in government, and specifically, NIH procurement processes as well as understanding of the scientific process and experience communicating with scientists concerning their need for supplies and services. Contractor's Requirements: 1. The Contractor shall understand and have experience with the policies and regulations concerning NIH procurement, including the New Business System (NBS) and have experience working with NIH contracting staff to implement large procurement actions. 2. The contractor shall design and maintain a product database that includes all items needed by the lab, with the quantities that the lab requires, as well as ordering information for their procurement. 3. The Contractor shall conduct weekly physical inventory of standard items, engage in discussions with the scientific staff to determine the special needs, and order preparation, in accordance with all NIH regulations. 4. The Contractor shall have experience in the execution of equipment purchases, including working with the scientists and procurement staff to fulfill all requirements for those purchases, including assisting in obtaining competitive quotes and editing justifications. 5. The Contractor shall perform regulatory tasks performing radioactive monitoring of the labs, including Geiger counter scanning, and wipe tests, both making the swipes and processing samples. 6. The Contractor shall understand and perform the implementation of NIH safety policies and programs, such as the allergy awareness program, LAPP. 7. The Contractor shall assist in the management of evacuation procedures and monitoring personnel (OEC), and must serve as safety officers, as required. 8. The Contractor shall ensure that the equipment in the lab is maintained, and service contracts kept up to date, as required by the lab. 9. The contractor shall comply with waste management procedures, and assist the lab staff for compliance with all recycling and waste/recycling regulations, including separation of lab waste and recyclables with implementation aids identified for the scientific staff, and monitoring tissue culture rooms and other common lab areas to encourage participation. D. Other Considerations: Quality Assurance: The supervision of this project and the contractor (including the determination of specific goals, evaluation of quality and timeliness of work) will be performed by the NHGRI Lab Management Staff. Government Responsibilities: Contractor shall have use of lab and office facilities located at the NIH, Building 49 or an equivalent location. Other NHGRI Government facilities will also be available to the contractor as determined necessary by the NHGRI. Reporting Requirements and Deliverables: The contractor shall work closely with the NHGRI/Government Staff and Lab Management members. Contractor shall communicate oral and written updates, as required by the NHGRI Staff. Program Management: Contractor shall work independently with no direct supervision but with the guidance of the Government. Inspection and Acceptance: The Government will review, inspect, and approve all documentation to guarantee that the work performed by the contractor is within the scope of the work that has been proposed for the contractor. Period of Performance: Base Year: 12 Months Option Year 1: 12 Months Option Year 2: 12 Months Option Year 3: 12 Months REGULATORY AUTHORITY This acquisition is conducted under the authority of 41 U.S.C. 253(c) as set forth in FAR Part 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements. ADDITIONAL INFORMATION Industry Classification (NAICS) Code is 541990, All Other Professional, Scientific and Technical Services, small business size standard is $15.0M. The acquisition is being conducted under FAR Part 13, simplified acquisition procedures, therefore the requirements of FAR Part 6 B Competitive Requirements are not applicable (FAR Part 6.001). The resultant Contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05-77 (November 13, 2014). This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by November 20, 2014 and must reference synopsis number HHS-NIH-NHLBI-CSB-(HG)-2015-021-DLM, may be submitted to the National, Heart, Lung and Blood Institute, Office of Acquisition, COAC Services Branch, 6701 Rockledge Drive, Suite 6149, Bethesda, Maryland 20892-7902, Attention: Dorothy Maxwell. Response may be submitted electronically to maxwelld@mail.nih.gov. Faxes will not be accepted. Responses will only be accepted if dated and signed by an authorized company representative. "All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency."

System Preventative Maint/Performance/Monitoring

Department of Health and Human Services, National Institutes of Health | Published November 17, 2014  -  Deadline November 26, 2014
cpvs

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is NICHD-15-006 and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-75. The North American Industry Classification (NAICS) Code is 811219 and the business size standard is $19m. However, this solicitation is not set aside for small business. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intend to procure on a sole source basis with Siemens Industry, Inc. - 6435 Virginia Manor Road - Beltsville, MD a one year preventative maintenance agreement for remote monitoring services of equipment/components and software services (in a scientific environment) for the animal facilities (Bldg 6B, NIH campus) and all aquatic facilities across the NIH main campus in Bethesda, MD. Equipment and software to be maintained and monitored: Equipment: Quantity: Modems 5 EACH Monitor 1 EACH PC Workstations 2 EACH Dot Matrix Printer 1 EACH Apogee Ethernet Modules 5 EACH Digital Point Unit 1 EACH Modular Building Controller 1 EACH Pump Control Relays 16 EACH Sump Level Sensors 5 EACH Immersed Temperature Sensors 13 EACH AOP Transducers 2 EACH Control Valves 2 EACH Solenoid Valves 4 EACH Mechanical Equipment Controllers 10 EACH Mechanical Equipment Controllers Point Blocks 5 EACH Apogee Software 1 EACH InfoCenter Software 1 EACH Uninterruptable Power Supplies 8 EACH Alarm Panels 3 EACH Services to Include (not limited to) The software services to include: (1) Annual software updates (2) Annual documentation updates (3) Graphics creation (4) Graphics backup (5) Field Panel Database/System File Backup (6) Software Consultation The System Performance Services to include: (1) On-line troubleshooting (2) Operator support (3) System Preventive Maintenance (4) Corrective Maintenance and Component Replacement (5) Account Management Emergency Service Options to include: (1) Provide emergency services (2) On-Line Response (3) On-Site Response Documentation and Quality Assurance to include: (1) Documentation of Service Provided (2) Quality Assurance Program Account Management Siemens is the sole manufacturer and servicer for the Seimens APOGEE and INFOCENTER software. Siemens Industry manufactured and installed all equipment and software for the monitoring and functions for all aspects of the aquatic systems. This includes but not limited to water quality, pump function, dosing modes and temperature. All these factors maintain the health and environment of the species housed in the aquatic facilities. Therefore it is critical that the services, etc being proposed must be able to adequately work/function with the existing equipment's and software, etc. The proposed contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under authority of the 41 U.S.C. 253(c) (1), FAR 6.302. Only one responsible source and no other supplies or services will satisfy agency requirements. The offeror must include a completed copy of the provision of FAR Clause 52.212-3, Offeror Representations and Certifications - Commercial Items with its offer. The provisions of FAR Clause 52.212-1 Instructions to Offerors - Commercial Items; FAR Clause 52.212-2, Evaluation - Commercial Items; FAR Clause 52.212-4, Contract Terms and Conditions - Commercial Items; and FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders - Commercial Items - Deviation for Simplified Acquisitions applies to this acquisition. The offeror must include their Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. The clauses are available in full text at http://www.acquisition.gov/far/. Interested vendors capable of furnishing the government with the specified services in this synopsis should submit a copy of their quotation to the below address or via email to robinsti@mail.nih.gov. Offers must also be accompanied by descriptive literature, delivery timeframe, warranties and/or other information that demonstrates that the offer meets all of the foregoing requirements. Quotations will be ten (10) calendar days from the publication date of this synopsis or by November 26, 2014 by 10 am, EST. via email or postal mail. The quotation must reference "Solicitation number" NICHD-15-006. Quotations sent by postal mail or other mailing services must be submitted to the following address: Eunice Kennedy Shriver National Institute of Child Health and Human Development, 6100 Executive Boulevard, Room 5C01, Bethesda, MD 20852. Attention: Tina Robinson, by the date and time mentioned above. Any questions must be sent via email to robinsti@mail.nih.gov and must include solicitation# NICHD-15-006 in the subject line of email. Faxed copies/responses will not be accepted. Note: In order to receive an award, contractor must be registered and have valid certification in the SAM database @www.sam.gov.